Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,8084,99,1.03 [0.34-3.15],0.958675887794741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,7888,96,0.92 [0.64-1.34],0.6799502003211217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,9153,102,1.04 [0.76-1.42],0.7970357585846387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,7826,99,1.52 [0.96-2.39],0.0730847573579367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,9101,106,0.80 [0.59-1.08],0.1401089650736339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,9153,102,0.95 [0.72-1.24],0.7033900819687462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,8070,98,1.12 [0.98-1.27],0.1023401869027697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,7826,99,0.95 [0.71-1.29],0.7537780003383676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",8987,101,0.93 [0.74-1.16],0.5017429755945684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",7935,94,0.79 [0.56-1.12],0.1890147314238905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",8064,99,0.86 [0.68-1.07],0.1791743259924473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,9100,103,0.58 [0.31-1.09],0.0931642497804208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,8070,98,1.63 [0.81-3.30],0.1735764143758464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,9015,102,0.91 [0.65-1.27],0.5679716425943948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,7921,97,1.18 [0.66-2.11],0.580692141690377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,8029,98,0.86 [0.72-1.02],0.0895675849031326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,9188,103,0.97 [0.69-1.37],0.8617146066044079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,7849,98,0.87 [0.55-1.36],0.5318958356463297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,9251,103,0.87 [0.49-1.55],0.6366710034477723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,9249,103,0.99 [0.78-1.27],0.9523641639858432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,8037,96,0.59 [0.33-1.04],0.0688367306655356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,7849,98,0.80 [0.45-1.44],0.4593551873501693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,7826,99,0.74 [0.41-1.35],0.3250046588157717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",9015,102,1.40 [1.00-1.94],0.0487787581323412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,7826,99,0.96 [0.68-1.37],0.8380621053369964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,9023,101,1.03 [0.61-1.74],0.9166958074150604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,9115,106,2.07 [1.11-3.88],0.0230004376771763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,9188,103,1.14 [0.86-1.50],0.36358125944163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,7826,99,0.86 [0.60-1.24],0.4103521692112173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,7886,96,0.83 [0.61-1.13],0.242286552614783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,9284,105,0.90 [0.54-1.52],0.7044837272356418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,9155,105,0.89 [0.59-1.34],0.5835629874371004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,7849,98,1.78 [1.07-2.97],0.0275743718461111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,9015,102,0.82 [0.46-1.46],0.5039752910266763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,9129,106,1.24 [0.76-2.02],0.3927012389719432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,9284,105,1.41 [0.84-2.36],0.1980229250190248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,9242,105,0.92 [0.50-1.71],0.8025410308167418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,8029,98,1.24 [0.66-2.33],0.5076026443171209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,7849,98,0.87 [0.45-1.69],0.6891506667233172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,9300,104,1.27 [0.60-2.70],0.5310127780718681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,9153,102,1.65 [1.08-2.52],0.0196616241769205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,9015,102,0.85 [0.46-1.55],0.5937962939265824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,7849,98,1.91 [1.22-3.00],0.005006301304188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,9229,104,1.18 [0.79-1.76],0.4091685418744736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,8080,98,1.79 [1.05-3.05],0.0326433320211749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,7888,96,1.39 [0.59-3.28],0.4544864736104165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,8064,99,0.97 [0.59-1.61],0.9143244864261566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,8987,101,1.05 [0.69-1.58],0.8334949602782842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,7921,97,0.75 [0.57-1.00],0.0467594629004856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,9115,106,1.37 [0.83-2.27],0.2170955186829403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,7921,97,1.66 [1.01-2.75],0.0457476977516704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,8029,98,1.03 [0.73-1.46],0.8774535939684497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,9238,106,0.91 [0.49-1.71],0.7751157031391691
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,9269,102,0.93 [0.51-1.68],0.805838162889589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,8064,99,0.50 [0.26-0.95],0.0347821936467386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,9153,102,1.11 [0.89-1.39],0.3392149579465689
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,9188,103,0.64 [0.33-1.23],0.1846843325898456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,7799,96,0.96 [0.71-1.28],0.7618204589762423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,7921,97,1.03 [0.80-1.33],0.8329197671691835
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,9015,102,1.20 [0.98-1.47],0.0752455133213738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,8084,99,0.74 [0.56-0.98],0.0340297038676679
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,9268,104,1.77 [0.88-3.56],0.1086974161540656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,7826,99,1.06 [0.81-1.38],0.6783038928596199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,7921,97,0.73 [0.56-0.94],0.015408762587732
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFM,Afamin,8084,99,2.88 [1.07-7.73],0.0360396528236655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,9103,106,1.13 [0.87-1.45],0.3619577411793073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,7799,96,1.12 [0.89-1.42],0.3366184587063445
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,9174,105,1.29 [0.85-1.95],0.2314559890509736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,8890,101,0.93 [0.78-1.11],0.4088194191324595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,8966,101,1.11 [0.83-1.47],0.4792128925466438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,9238,106,1.50 [0.93-2.42],0.0933878953833334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,9284,105,1.66 [1.18-2.35],0.0037488040175902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,8070,98,1.69 [0.80-3.56],0.1711376661167704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,9188,103,0.95 [0.75-1.20],0.660738796208516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,9188,103,0.72 [0.55-0.93],0.0125772324013638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,7888,96,1.02 [0.55-1.91],0.9462255225833668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,7888,96,1.92 [1.11-3.34],0.0204239093760657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,8037,96,0.71 [0.50-1.02],0.0604948799437896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,8070,98,1.43 [0.69-2.97],0.3325342889080949
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,9184,104,1.21 [0.99-1.47],0.0575251224109496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",7852,92,1.12 [0.91-1.38],0.2727680306594066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,8987,101,0.97 [0.69-1.37],0.8729688211840775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,7888,96,1.04 [0.75-1.45],0.8023624610168948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",9138,102,0.94 [0.79-1.12],0.4941552327568879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,9188,103,0.98 [0.75-1.28],0.8881574157474231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",8060,98,0.96 [0.80-1.16],0.697687272282516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,7921,97,1.15 [0.48-2.73],0.7520944308737935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,8987,101,0.88 [0.69-1.12],0.3111647583954851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,7852,92,0.73 [0.51-1.04],0.0827472996551976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,9015,102,0.74 [0.50-1.10],0.1362376972731357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,7849,98,1.07 [0.82-1.40],0.6066944020710673
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,8968,102,0.94 [0.72-1.23],0.6585097443452286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,8052,99,0.90 [0.77-1.05],0.1686421716354477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,8945,100,0.72 [0.52-0.99],0.046325144564729
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,9300,104,0.75 [0.31-1.85],0.5397553814447793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,9199,105,0.97 [0.71-1.32],0.845763900516052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",8037,96,1.00 [0.68-1.46],0.9896921969188748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",9151,106,1.12 [0.91-1.38],0.2972663310860423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",8052,99,0.89 [0.58-1.35],0.5753858989528224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,7935,94,0.87 [0.54-1.39],0.5496177228714391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,7849,98,1.02 [0.87-1.19],0.807587210279177
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",9153,102,1.31 [1.11-1.56],0.001862810868088
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,9023,101,1.38 [0.85-2.25],0.1914325076492817
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,9251,104,0.83 [0.36-1.92],0.6601491970833993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,8080,98,1.43 [0.66-3.06],0.3629760505146603
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,8968,102,0.70 [0.50-0.98],0.0369925666650775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,7852,92,1.06 [0.72-1.56],0.7634614341041978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,9153,102,0.99 [0.46-2.13],0.97959519910337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,9023,101,0.88 [0.60-1.29],0.5094796896779517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,7921,97,1.27 [0.78-2.05],0.3376645409410439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,8005,95,1.13 [0.77-1.65],0.5285985188071788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,8060,98,1.12 [0.87-1.46],0.3809122821675079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,7534,93,1.10 [0.76-1.59],0.607410500251232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,8803,98,1.05 [0.73-1.53],0.7816707741170361
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,8555,94,1.02 [0.70-1.49],0.9174135642111472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,9188,105,1.02 [0.61-1.68],0.9489038547598322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,9156,105,0.98 [0.80-1.20],0.8506541597682709
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,9268,104,1.73 [1.12-2.69],0.0141099592976203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,9068,102,0.82 [0.44-1.52],0.5258628272788899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,9209,106,1.08 [0.71-1.65],0.7101269594657003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,9207,106,0.89 [0.55-1.43],0.6319510714945864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,9220,106,0.94 [0.63-1.39],0.7405933813578842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,9268,104,1.08 [0.67-1.73],0.7565425996785994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,7826,99,1.21 [0.99-1.49],0.0666485507779723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,7849,98,0.85 [0.66-1.09],0.2114837779517656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,7791,95,1.03 [0.74-1.44],0.8565620091496702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,8987,101,1.00 [0.74-1.35],0.9922628420047506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,7888,96,1.02 [0.64-1.62],0.948139942151144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,9235,106,0.63 [0.33-1.20],0.1626697950531482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,7874,96,0.73 [0.44-1.21],0.2189024264765742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,8968,102,1.03 [0.84-1.27],0.7457438763214852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,9157,106,0.77 [0.61-0.97],0.0253829551601511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,7769,95,1.00 [0.76-1.32],0.9926246652450518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,9242,105,0.75 [0.58-0.96],0.0213103221842896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,9145,103,0.78 [0.61-1.01],0.060592328191006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,8946,102,0.66 [0.36-1.20],0.1736226299178405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],9023,101,1.12 [0.87-1.45],0.3815091016966054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,9245,106,0.80 [0.45-1.41],0.4390275875994082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,8037,96,0.84 [0.65-1.08],0.1677406730599873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,7852,92,0.91 [0.59-1.41],0.6842806907792567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,8029,98,0.87 [0.68-1.13],0.303519968095807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,8060,98,1.14 [0.76-1.70],0.5264459900147243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,9153,102,0.95 [0.63-1.44],0.810557054774295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,8003,98,0.97 [0.55-1.71],0.9142760404209564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,9234,103,0.78 [0.57-1.07],0.1210649977682598
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,9188,103,0.82 [0.58-1.16],0.2567257535925774
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,8084,99,1.25 [0.65-2.39],0.506759914437406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,8070,98,0.90 [0.61-1.32],0.600046072426954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,8084,99,1.12 [0.68-1.84],0.6555526350659276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,8070,98,1.83 [0.76-4.40],0.1782493176832938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,7888,96,0.85 [0.54-1.34],0.4864336536762005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,8067,99,0.89 [0.50-1.57],0.6823502302695688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,7734,98,1.20 [0.81-1.78],0.3597774865563657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,8084,99,1.08 [0.84-1.38],0.5654878770848982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,8070,98,0.66 [0.40-1.10],0.1096124948045053
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,9199,105,0.93 [0.57-1.52],0.7809824464814551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,8070,98,0.95 [0.69-1.30],0.7586669378384961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,9226,106,0.67 [0.36-1.25],0.2080988782830079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,9191,105,0.93 [0.72-1.21],0.5994858661821605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,7921,97,0.88 [0.74-1.05],0.1543081631703592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,9117,106,0.80 [0.56-1.15],0.2272413083230514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,7935,94,0.91 [0.67-1.23],0.5264701191557878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,9153,102,1.20 [0.81-1.77],0.3693668372345869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,8029,98,0.84 [0.71-1.01],0.0618821967852838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,8052,99,1.00 [0.75-1.33],0.990745151271086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,9147,100,1.09 [0.78-1.52],0.6148018835080027
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",8037,96,0.79 [0.48-1.28],0.3368891202606058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,8987,101,0.78 [0.52-1.15],0.2115878903640403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,8987,101,0.88 [0.63-1.21],0.4314301514782078
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,7935,94,1.38 [0.92-2.08],0.1214305997591712
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,7921,97,0.82 [0.64-1.05],0.114626493100986
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,7791,95,1.02 [0.81-1.29],0.8502873365571572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,8060,98,0.92 [0.74-1.14],0.4295861721282055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,8052,99,0.94 [0.76-1.16],0.5419527010942834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,9168,106,0.90 [0.76-1.06],0.205797917946281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,7799,96,0.77 [0.56-1.04],0.0882472667694387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,7799,96,0.64 [0.37-1.11],0.1155410061767959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,8968,102,0.96 [0.63-1.46],0.8338638971710481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,7826,99,0.75 [0.55-1.03],0.0744202364678865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,7826,99,0.65 [0.39-1.08],0.0994196043442303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,7799,96,0.91 [0.65-1.27],0.5673311181409582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,9023,101,1.08 [0.67-1.72],0.7606288849573718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,7826,99,1.18 [0.86-1.61],0.2983673610465974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,9199,105,0.85 [0.57-1.27],0.4314517943168728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,9153,102,0.85 [0.61-1.19],0.3424309191680084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,9245,106,0.92 [0.55-1.52],0.7345899923669172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,7799,96,0.74 [0.50-1.10],0.1415918502902906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,9023,101,0.76 [0.47-1.23],0.2573889156362815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,7990,96,0.81 [0.51-1.27],0.3509996235066852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,9129,106,1.29 [0.90-1.87],0.1698446516473917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,9129,106,1.54 [0.87-2.73],0.1374830943140412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,8070,98,1.09 [0.53-2.24],0.8104384306955168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,8064,99,0.98 [0.50-1.92],0.943999140936942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,8052,99,0.99 [0.74-1.32],0.9401477760812929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,7888,96,1.03 [0.85-1.25],0.7957431185510413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,7826,99,0.98 [0.77-1.26],0.8926429047268165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,8968,102,1.02 [0.79-1.32],0.8730149821577604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,7791,95,1.15 [0.68-1.93],0.5983221576264209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,8029,98,0.89 [0.70-1.12],0.3242813541937644
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,8987,101,0.96 [0.71-1.29],0.7756893812160441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,9229,104,0.88 [0.68-1.13],0.3013973975622024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,7826,99,0.99 [0.67-1.47],0.9628348109856664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,7826,99,1.19 [0.69-2.06],0.527082252192312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,7826,99,1.18 [0.77-1.79],0.4482580267593476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,7791,95,0.81 [0.48-1.34],0.4102393346376046
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,7826,99,1.26 [0.98-1.61],0.0736797027981371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",7826,99,1.15 [0.84-1.56],0.3827595984437593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",9238,106,0.83 [0.71-0.96],0.014105016707534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",8968,102,0.79 [0.50-1.24],0.3012130614561353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,8987,101,1.51 [1.11-2.04],0.0079025738548713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,9153,102,0.96 [0.50-1.84],0.9013609513225664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,8949,102,0.93 [0.71-1.22],0.6045960114233594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,7888,96,0.98 [0.75-1.30],0.9122195789080392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,7826,99,0.88 [0.72-1.09],0.2396929695238698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,8029,98,1.00 [0.50-1.96],0.9889136320324032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",8084,99,1.47 [0.46-4.67],0.5167468061799274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,8968,102,0.79 [0.64-0.98],0.0340381567437695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,7799,96,0.95 [0.80-1.14],0.5986743850867762
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,8052,99,1.48 [1.04-2.11],0.0290016484831381
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,8060,98,0.99 [0.73-1.35],0.9697800086459264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,9168,106,0.88 [0.74-1.06],0.1882203821394444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,9245,106,1.38 [0.75-2.55],0.2970853542862312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,8052,99,0.90 [0.63-1.29],0.5704970308820019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,8903,100,0.84 [0.66-1.08],0.1851440228234713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,8084,99,1.50 [1.05-2.13],0.0243912497456946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,7826,99,1.08 [0.43-2.74],0.868673162830888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",7888,96,1.19 [0.69-2.06],0.5375466308646748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",9238,106,0.76 [0.41-1.43],0.3952921824696374
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",9199,105,0.62 [0.29-1.29],0.1972214112707451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,7849,98,1.00 [0.53-1.90],0.9945506946334872
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,9168,106,0.84 [0.66-1.08],0.1740127953625665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,9115,106,1.25 [0.81-1.95],0.3140734761973768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,7849,98,0.75 [0.48-1.16],0.2002785981578141
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,9015,102,0.93 [0.56-1.55],0.7895891665647252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,8987,101,0.90 [0.68-1.20],0.4784760805452551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,8987,101,0.88 [0.48-1.64],0.6934641578684351
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,9168,106,0.89 [0.76-1.05],0.167862772870759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,8060,98,1.03 [0.78-1.37],0.8204756186345805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,7852,92,1.00 [0.80-1.25],0.9873785382244162
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,8957,102,0.83 [0.67-1.02],0.08000967071363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,9199,105,1.63 [0.81-3.28],0.1685432975837271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,9129,106,0.91 [0.55-1.51],0.7227788192634448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",8064,99,1.23 [0.67-2.28],0.5005429109931951
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",7799,96,1.18 [0.86-1.61],0.2986273347678536
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,7924,95,1.26 [0.60-2.68],0.5396021545432976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,8029,98,1.17 [0.85-1.59],0.3345240767398592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,8060,98,0.86 [0.70-1.04],0.1235023864262706
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",9168,106,0.91 [0.63-1.33],0.6346187545485862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,7849,98,0.93 [0.66-1.32],0.6902549917426208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,7791,95,0.82 [0.58-1.16],0.2580962515987322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,8037,96,1.02 [0.66-1.58],0.9272887109367948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,9168,106,0.86 [0.71-1.04],0.1199867722529446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,8080,98,1.00 [0.79-1.26],0.9996605593194232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,7888,96,0.96 [0.69-1.34],0.8068970640886497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,7791,95,1.36 [1.03-1.80],0.0312075826548497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,8080,98,0.91 [0.74-1.13],0.3909023019398744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,8966,101,1.01 [0.87-1.17],0.8886055715299024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,7799,96,1.23 [0.98-1.55],0.0729871086383758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,7826,99,1.19 [0.55-2.56],0.65842215920218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,9168,106,0.84 [0.65-1.10],0.2104938764426831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,9199,105,0.83 [0.69-1.01],0.0665956096740773
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,8987,101,0.79 [0.59-1.06],0.1118025812552993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,9300,104,0.59 [0.37-0.93],0.0238755459871394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,7849,98,0.97 [0.57-1.65],0.9177622139170004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,7799,96,0.87 [0.65-1.17],0.3476815925331696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,8060,98,0.89 [0.54-1.48],0.6655845842474745
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,9199,105,1.11 [0.87-1.42],0.3860020830963498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,7921,97,0.64 [0.33-1.24],0.1866676408102981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,9115,106,1.00 [0.68-1.48],0.9859251993332708
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,9005,101,1.21 [0.78-1.86],0.3896508766941399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,7921,97,1.81 [0.79-4.15],0.1639280849120697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,8064,99,1.06 [0.59-1.90],0.8430144419472746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,7849,98,0.84 [0.53-1.35],0.4789655097932519
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,9015,102,1.32 [0.62-2.82],0.4772754634804348
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,7799,96,0.72 [0.47-1.08],0.1090596070781521
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,7888,96,1.05 [0.73-1.51],0.7804820381190409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,7605,90,0.90 [0.74-1.08],0.2586034089149278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,9151,101,0.86 [0.65-1.14],0.2906948567402083
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,8049,99,0.97 [0.75-1.25],0.8143245752491871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,7952,98,0.86 [0.72-1.03],0.1025583611244235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,7935,94,1.22 [0.68-2.20],0.5112395031178789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,7799,96,1.08 [0.63-1.85],0.7778135116394591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,7826,99,1.05 [0.71-1.56],0.8086628308690589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,7826,99,0.87 [0.51-1.49],0.6101238169814303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,8968,102,0.89 [0.59-1.33],0.5649506258895003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,7799,96,0.93 [0.58-1.48],0.747915272147059
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,8052,99,1.11 [0.70-1.76],0.6686522564913493
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BSG,Basigin,9270,104,1.08 [0.47-2.50],0.8507527493795133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BSND,Barttin,7791,95,1.42 [0.92-2.19],0.1102187486112337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,9263,106,0.91 [0.65-1.28],0.5884549488018065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,9263,106,0.93 [0.66-1.30],0.6664382787235935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,8987,101,0.77 [0.59-1.00],0.0477357507744608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,8084,99,0.82 [0.33-2.04],0.6712608837761809
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,7791,95,0.95 [0.74-1.23],0.7207950419659095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,8021,95,1.24 [0.91-1.70],0.1784860755150069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,9238,106,1.01 [0.53-1.95],0.9726747644601476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,9168,106,0.84 [0.53-1.33],0.4579802797052411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,7791,95,1.16 [0.78-1.74],0.4631223292544539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,8968,102,1.03 [0.79-1.33],0.832714616804547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,7826,99,0.81 [0.43-1.53],0.5135513447942863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,9240,104,0.68 [0.31-1.51],0.3458816928862981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",8052,99,0.72 [0.49-1.06],0.098681653193027
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,7849,98,0.88 [0.56-1.38],0.5859716133431951
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,9245,106,1.08 [0.73-1.59],0.6909220012278945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,7921,97,1.40 [0.83-2.38],0.2091830909628013
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,8052,99,1.42 [0.87-2.32],0.1643146027841982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,7904,97,0.92 [0.63-1.36],0.6861378836193814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,8084,99,1.41 [0.58-3.41],0.4453666773584179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,8071,98,1.60 [0.59-4.40],0.3580078378033487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,8084,99,1.05 [0.42-2.63],0.9146021176790397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2,Complement C2,9226,106,0.82 [0.41-1.62],0.5668196054169614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,8949,102,0.83 [0.54-1.29],0.415619119204334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,7852,92,0.76 [0.50-1.16],0.2074996912653488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C3,Complement C3,7672,93,1.14 [0.74-1.74],0.5607898194940133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,9229,104,0.54 [0.35-0.83],0.0043998601235269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C5,Complement C5,8084,99,1.07 [0.30-3.83],0.9188235153803972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,7878,97,0.73 [0.40-1.35],0.3166798336303144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,8060,98,0.83 [0.32-2.17],0.7019743844068479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,8084,99,1.34 [0.71-2.52],0.3719800764044246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,8070,98,0.85 [0.58-1.23],0.3868410147559201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,8029,98,1.10 [0.88-1.38],0.4069905397681294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,9007,104,1.15 [0.88-1.51],0.3012444651873848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,8987,101,1.13 [0.70-1.82],0.6152964645426109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,9153,102,0.98 [0.56-1.70],0.938467053593081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,9111,103,0.85 [0.72-1.00],0.0498575987019022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,9268,104,0.95 [0.57-1.56],0.832152266337045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,9163,103,1.04 [0.82-1.32],0.7415393313593149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,9286,104,1.00 [0.76-1.34],0.9765815416107289
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,9300,104,0.72 [0.34-1.50],0.3785685293552249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",9015,102,1.01 [0.83-1.22],0.9507124575323602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,9165,104,1.09 [0.82-1.44],0.5535177137670557
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,7935,94,0.83 [0.46-1.47],0.5161293518183081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,7849,98,1.13 [0.61-2.11],0.6946462739131724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,9268,104,0.89 [0.63-1.27],0.5303492638582123
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,7852,92,1.11 [0.83-1.49],0.47839607650961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,7799,96,0.90 [0.50-1.64],0.7338356467163022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,7826,99,0.95 [0.69-1.32],0.7753374912959559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,7799,96,1.01 [0.73-1.40],0.936527595785603
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,8052,99,0.91 [0.72-1.15],0.4196118080540472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,7907,97,0.85 [0.70-1.03],0.1016218894753134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,7852,92,0.66 [0.37-1.17],0.1521960762424129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,9153,102,0.82 [0.56-1.20],0.3072627516913354
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,8968,102,0.97 [0.56-1.68],0.9189472279713222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,9110,106,1.11 [0.82-1.49],0.4954660472242246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,8060,98,1.27 [0.86-1.88],0.2369306231759298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,9234,102,0.93 [0.78-1.10],0.3868628784777301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,7888,96,0.87 [0.67-1.14],0.3187215733729884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,7826,99,1.09 [0.69-1.74],0.7042527102096853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,8987,101,0.90 [0.58-1.39],0.6325359095097509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,7852,92,0.78 [0.52-1.17],0.2294344211672771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,8052,99,0.95 [0.79-1.14],0.6047876953676503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,9154,103,1.02 [0.43-2.43],0.9557381428139224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,9119,101,0.74 [0.54-1.01],0.0592166472748858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,8037,96,1.31 [0.86-1.98],0.2090050283846147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,8060,98,0.89 [0.70-1.12],0.313991606145786
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,8968,102,1.26 [0.92-1.73],0.1461549922033984
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,7852,92,0.93 [0.57-1.53],0.7849046518666336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,8968,102,0.94 [0.73-1.23],0.6710417330164108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,8968,102,0.84 [0.65-1.08],0.162294876372239
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,9168,106,0.84 [0.65-1.09],0.1999442072188993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,9300,104,0.82 [0.67-0.99],0.0444254833884164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,7935,94,1.04 [0.93-1.15],0.4956857146329483
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,8060,98,0.88 [0.70-1.12],0.2946843875348812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,9232,103,0.75 [0.56-1.02],0.0628102746970025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,7849,98,0.91 [0.65-1.26],0.5636424275843555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,7826,99,1.02 [0.69-1.52],0.9155529676420776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAT,Catalase,7952,96,1.07 [0.75-1.51],0.7117504736103231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,9172,103,0.98 [0.79-1.21],0.850678672489693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,7799,96,0.86 [0.67-1.10],0.2228598807023772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,9268,104,1.06 [0.63-1.80],0.8232951155178634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,7888,96,1.03 [0.70-1.51],0.8978080910326929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,7826,99,1.11 [0.74-1.67],0.6101604878703888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,9129,106,0.94 [0.74-1.20],0.626839482141473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,8060,98,0.68 [0.42-1.11],0.1234164297693545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,8037,96,0.99 [0.67-1.48],0.9698869407721592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,7852,92,0.80 [0.40-1.60],0.5348055057805325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,8052,99,0.91 [0.70-1.18],0.4762110433587123
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,9188,103,1.49 [0.94-2.35],0.0863305497900226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,7888,96,1.13 [0.84-1.53],0.4179997388832128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,9284,105,1.54 [0.96-2.48],0.0725274982851013
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,9265,105,1.04 [0.81-1.33],0.777181698523804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,9188,105,1.15 [0.75-1.76],0.5237672791823413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,9300,104,1.04 [0.70-1.55],0.8391413524761546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,9300,104,1.23 [0.88-1.74],0.2285882542724139
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,9189,105,1.02 [0.84-1.23],0.8532100031537402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,9074,104,1.03 [0.81-1.33],0.7920756777060353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,9263,106,1.07 [0.96-1.20],0.2430910285623152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,9115,106,1.32 [0.97-1.79],0.0752331559054145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,9284,105,0.90 [0.73-1.10],0.2908799753706378
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,9238,106,1.47 [1.14-1.91],0.0035853520080764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,9122,105,1.08 [0.78-1.50],0.6477336305375117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,9238,106,1.09 [0.72-1.65],0.671440859792283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,9220,106,1.30 [1.07-1.59],0.0099271256194024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,9284,105,0.93 [0.64-1.35],0.709731356193452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,9168,106,1.07 [0.91-1.27],0.4159737091321075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,9188,103,1.19 [0.88-1.61],0.2649336331924959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,9133,106,1.00 [0.74-1.35],0.978295422361902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,9168,106,1.12 [0.87-1.44],0.3771983228454322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,9219,105,1.10 [0.89-1.35],0.3880895166550608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,9245,106,0.95 [0.80-1.13],0.5573711680111522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,9168,106,1.02 [0.76-1.37],0.8753064363755666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,9251,104,1.00 [0.75-1.33],0.99310674811281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,9132,102,1.20 [0.94-1.53],0.1372911237243378
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,9182,105,1.04 [0.76-1.42],0.7943148111812033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,9284,104,1.03 [0.63-1.69],0.9104077058148212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,9268,104,1.18 [0.78-1.78],0.4274185818415709
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,9199,105,1.22 [0.79-1.90],0.364403245712798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,7935,94,0.90 [0.53-1.53],0.7051301433680692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,7849,98,1.03 [0.83-1.27],0.8185612115728313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,9129,106,1.04 [0.73-1.48],0.838281406970579
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,8987,101,1.21 [0.83-1.76],0.3280221495764904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,8029,98,1.33 [0.85-2.09],0.209926280072191
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,9199,105,0.88 [0.52-1.50],0.6470080292206176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,9028,101,0.67 [0.43-1.05],0.081737093074409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,9284,105,1.19 [0.83-1.70],0.3492218064543416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,9245,106,0.88 [0.59-1.33],0.5541421375192426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,9199,105,0.66 [0.31-1.40],0.2781332672606456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,7852,92,1.39 [0.87-2.24],0.1680179721141219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,9188,103,0.93 [0.82-1.05],0.2633057531770731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,9229,104,0.95 [0.46-1.94],0.8803566338432816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,7826,99,1.28 [0.88-1.87],0.1980319825625063
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,9168,106,0.81 [0.42-1.58],0.5408743377686362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,9137,106,0.63 [0.38-1.06],0.0839808041909162
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,8973,101,1.35 [0.86-2.12],0.1951503148042655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,9219,103,0.89 [0.57-1.39],0.6063806287112111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,9284,105,1.17 [0.77-1.77],0.4752758350562139
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,7849,98,0.84 [0.52-1.34],0.4578864356110895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,9284,105,1.20 [0.62-2.30],0.5869421883033232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,8080,98,0.83 [0.52-1.35],0.4616192642474142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,9229,104,0.83 [0.54-1.27],0.3806096269835152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,9129,106,0.96 [0.58-1.60],0.8882155453586495
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,9191,106,1.11 [0.69-1.79],0.678023852776836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,8987,101,1.18 [0.74-1.87],0.4797897929845126
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,9188,103,0.97 [0.74-1.27],0.8088595961962599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,7921,97,1.10 [0.58-2.09],0.7669337020166338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,9263,106,1.08 [0.66-1.76],0.7588891314114414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,9233,104,1.16 [0.76-1.75],0.4970620866192209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,9268,104,1.21 [0.89-1.64],0.2173123787624237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,9199,105,0.69 [0.43-1.08],0.1059688989927287
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,9153,102,1.52 [0.89-2.60],0.1237921859103346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,9229,104,0.86 [0.70-1.05],0.1351722524459903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,9239,106,0.68 [0.33-1.39],0.2853790346002084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,7849,98,1.00 [0.63-1.57],0.994747828104076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,9153,102,1.53 [0.89-2.63],0.1259785390497307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,7799,96,1.82 [1.24-2.66],0.0020550562872576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,7935,94,1.19 [0.79-1.80],0.4065558083942698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,7849,98,1.02 [0.82-1.25],0.875348548326175
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,9150,106,1.75 [1.22-2.51],0.0022818951024612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,9201,105,0.62 [0.42-0.92],0.0161376424974727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,9284,105,0.96 [0.76-1.20],0.6942781626027736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,9161,105,0.64 [0.33-1.23],0.1829308213674856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,9220,106,0.72 [0.40-1.28],0.2613332693273509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,9251,104,1.00 [0.59-1.69],0.9963808338307286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,8888,101,0.77 [0.38-1.55],0.4615974689439531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,9185,106,0.92 [0.35-2.44],0.867607735695985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,8875,100,1.21 [0.57-2.56],0.6189480995515921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,8033,98,1.56 [1.04-2.35],0.0322907601573488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,9270,104,0.97 [0.70-1.34],0.8343573503743749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,9115,106,0.83 [0.59-1.16],0.2703744073150143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,9161,102,0.83 [0.68-1.01],0.0692737661196523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,7830,98,1.09 [0.69-1.71],0.7131247847894076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,9168,106,0.88 [0.58-1.33],0.5325506658706585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,7921,97,1.29 [0.82-2.03],0.2769601194563387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,9263,106,0.98 [0.59-1.61],0.9230998163817068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,9284,105,0.83 [0.55-1.23],0.3465126513188338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,8064,99,1.17 [0.67-2.05],0.5817544560367616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,7935,94,0.73 [0.42-1.27],0.2703006165316543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,9168,106,1.29 [0.78-2.12],0.3186802297898344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,9168,106,0.73 [0.42-1.27],0.2635638855617477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,8029,98,0.76 [0.38-1.52],0.4429637662321364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,9263,106,0.88 [0.62-1.24],0.4572246624584096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,8860,104,1.15 [0.66-2.01],0.6103784873961577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,9199,105,0.73 [0.30-1.78],0.4873208616411055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,9199,105,1.06 [0.50-2.21],0.8843925022059649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,8043,98,0.91 [0.60-1.38],0.6545329176107724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,8060,98,1.15 [0.56-2.35],0.6965849598914502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,7791,95,1.09 [0.81-1.45],0.5802821451369031
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,7791,95,0.90 [0.54-1.51],0.6899076912604497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,8015,98,0.78 [0.58-1.04],0.0926136565264825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,8987,101,0.94 [0.70-1.27],0.6817057509775432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,9229,104,0.80 [0.65-0.99],0.0417857608615735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,8029,98,0.96 [0.80-1.17],0.6955290564095158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,9129,106,0.86 [0.61-1.22],0.4046737653020987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,8909,101,1.02 [0.64-1.60],0.946196628341402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,9244,106,1.14 [0.83-1.57],0.4068617153686633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,9188,103,1.09 [0.85-1.40],0.5016748471210732
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,9188,103,1.35 [0.82-2.20],0.2365872359473856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,7935,94,1.48 [0.86-2.54],0.1597626456131819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,8060,98,1.93 [1.01-3.71],0.0480529481654335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,9263,106,2.31 [1.58-3.37],1.5163248306950183e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,7799,96,0.94 [0.62-1.41],0.7508902935097939
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,9300,104,0.92 [0.52-1.64],0.780483802345016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,9188,103,0.90 [0.57-1.44],0.6709237542884128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,8968,102,1.07 [0.72-1.60],0.7391793708456362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,9153,102,1.14 [0.90-1.44],0.27995846651571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,9188,103,1.76 [1.07-2.89],0.0246832964314725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,7791,95,1.54 [0.92-2.59],0.1008788582623222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,8052,99,0.83 [0.58-1.20],0.3240433755672376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,7799,96,1.29 [0.98-1.69],0.0698593338342882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,9153,102,1.00 [0.84-1.18],0.9601370121478168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,9153,102,0.84 [0.70-1.00],0.0500222811884453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,9153,102,1.15 [0.68-1.94],0.5942383936602571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,9208,106,1.36 [0.69-2.68],0.3790382019991405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,9248,105,1.21 [0.82-1.79],0.3348254623984601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,9213,104,0.59 [0.29-1.21],0.1488470448985827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,8029,98,0.98 [0.75-1.27],0.8655066967972046
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,7935,94,1.12 [0.87-1.43],0.3750894123457438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,8029,98,1.44 [0.92-2.28],0.1142660073475181
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,7935,94,1.15 [0.78-1.70],0.4730106509266432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,9168,106,0.84 [0.68-1.03],0.0994768102881094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,8987,101,0.59 [0.39-0.90],0.0141669879333806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,8885,101,0.91 [0.69-1.20],0.5172146972514509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,8080,98,0.72 [0.42-1.22],0.2210816683310474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,9015,102,0.92 [0.63-1.33],0.6408100886499929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,7849,98,1.16 [0.73-1.87],0.5289787063043889
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,9015,102,0.88 [0.55-1.42],0.6045500156544813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,8080,98,1.20 [0.87-1.65],0.2696690076174096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,9284,104,1.08 [0.80-1.45],0.6300271381753926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,7921,97,2.39 [1.29-4.45],0.0059329340738987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,7849,98,1.00 [0.57-1.76],0.9993248867167314
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,7799,96,1.14 [0.86-1.50],0.3555799665887227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,7935,94,0.94 [0.65-1.36],0.7372034651082255
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,7935,94,0.97 [0.72-1.30],0.8272909737749284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,7826,99,0.67 [0.38-1.19],0.1703972896594364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,7791,95,0.99 [0.61-1.62],0.96826188585456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,9023,101,1.03 [0.80-1.33],0.8189546050364789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,7888,96,1.01 [0.77-1.31],0.9506564742270408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,8987,101,0.81 [0.63-1.04],0.0936448262332019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,7935,94,0.94 [0.64-1.38],0.7607323874127006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,7791,95,1.11 [0.70-1.77],0.6531718661260695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,8947,102,0.93 [0.72-1.21],0.5931636070091769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,8987,101,0.86 [0.64-1.15],0.2959359627345796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,8968,102,0.73 [0.54-0.97],0.033022507455556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,9217,103,1.06 [0.86-1.30],0.5754262595780251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,9153,102,0.94 [0.68-1.29],0.6958097437227249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,9153,102,1.09 [0.86-1.38],0.4829046395005899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,8968,102,0.75 [0.56-0.99],0.0449954015547422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,8029,98,0.73 [0.56-0.96],0.0224550334681777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,7934,96,1.51 [0.81-2.84],0.1971745117221484
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,8987,101,1.04 [0.69-1.57],0.8363707387154817
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,8084,99,1.92 [0.83-4.45],0.1271371481062993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,7594,89,2.73 [1.14-6.55],0.024135913690095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,8022,98,1.21 [0.85-1.71],0.2947534245400319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,8070,99,1.01 [0.78-1.31],0.9352992752046692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,7952,97,1.05 [0.66-1.68],0.8401813268069327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,8084,99,1.83 [0.69-4.89],0.2277597188296382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFP,Properdin,8084,99,1.09 [0.45-2.62],0.8556859276062003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,9199,105,1.12 [0.83-1.51],0.4534248510780652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,8070,98,1.29 [0.78-2.14],0.3248231206594069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,7852,92,1.50 [1.11-2.03],0.0078769600562198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,9188,103,1.18 [0.78-1.77],0.4363113448797074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,8987,101,0.98 [0.73-1.31],0.9047614194114462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,7921,97,0.86 [0.60-1.25],0.4375464037838714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",8060,98,0.93 [0.56-1.53],0.7754487523868752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,8037,96,1.01 [0.50-2.07],0.9683954416770028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,9015,102,0.70 [0.40-1.20],0.1912713275019807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,8080,98,0.93 [0.77-1.13],0.4539953759796606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,9229,106,1.12 [0.74-1.70],0.5794539106621514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,9027,105,0.98 [0.78-1.23],0.8531373503662086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,9235,102,0.94 [0.85-1.04],0.2390217522656049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,9233,106,0.75 [0.42-1.34],0.3350658409174463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,7852,92,0.96 [0.69-1.33],0.7971521905105108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,9129,106,0.85 [0.68-1.05],0.1389174541989891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,8064,99,0.81 [0.57-1.16],0.2503400407097819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,7799,96,1.11 [0.87-1.42],0.3887915092028468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,9220,106,1.09 [0.62-1.91],0.7686899652287514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,9188,103,2.70 [1.94-3.76],4.2324461517936835e-09
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,7852,92,1.26 [0.79-2.02],0.329514306654573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,9229,104,0.79 [0.60-1.04],0.0984282496231737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,8080,98,1.39 [0.95-2.02],0.0864216322175475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,7935,94,1.43 [1.02-2.01],0.03668290563237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,8029,98,0.83 [0.67-1.02],0.0706105308214351
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,7852,92,1.11 [0.71-1.71],0.653704875481086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,9251,103,0.98 [0.52-1.86],0.9495444341086996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,8080,98,0.84 [0.61-1.15],0.2700927607952211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",9178,105,0.88 [0.72-1.08],0.2224678802879515
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,7791,95,1.20 [0.95-1.53],0.1239186019798607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,9171,103,1.01 [0.77-1.33],0.9275156927100155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,9129,106,0.71 [0.44-1.15],0.1637001138340952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,9180,105,0.80 [0.56-1.14],0.2152122240595663
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,7849,98,1.24 [0.50-3.11],0.6417401996340304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,9199,105,0.96 [0.56-1.65],0.8882684432289014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,9015,102,0.91 [0.53-1.54],0.7173840094377988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,9263,106,0.90 [0.75-1.08],0.2528082307512375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,7852,92,1.35 [1.00-1.83],0.0488423342669443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,7884,96,2.31 [1.08-4.95],0.0313682075316235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,9168,106,0.59 [0.37-0.95],0.0312197608403186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,9168,106,1.17 [0.81-1.67],0.4023868367784829
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,9168,106,1.22 [0.93-1.61],0.1452231565931714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,9168,106,0.93 [0.55-1.57],0.7883474139396935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,8067,98,0.97 [0.65-1.44],0.8638033204850049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,9170,102,0.83 [0.45-1.52],0.5392683335417685
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,8987,101,0.88 [0.59-1.30],0.5097203310202876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,9284,105,1.20 [0.86-1.67],0.2777122695138288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,7852,92,0.84 [0.53-1.35],0.4711754309886929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,7852,92,0.83 [0.42-1.62],0.5790570850778285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,7791,95,1.26 [0.93-1.71],0.1331545283219481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,9168,106,0.92 [0.79-1.07],0.2989837633894557
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,9268,104,1.76 [0.76-4.05],0.1846849647677936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,7852,92,0.92 [0.49-1.70],0.7800228375986447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",9110,106,0.92 [0.77-1.11],0.3871817369102954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,9184,104,0.97 [0.76-1.24],0.8054389697485144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,8949,102,0.72 [0.39-1.34],0.2970429611443791
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,8968,102,1.06 [0.77-1.46],0.710328486999904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,9284,105,1.33 [0.88-2.01],0.1726130785651292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,8060,98,2.38 [1.37-4.12],0.0019844689348065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,9015,102,1.00 [0.69-1.45],0.9901779135813362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,8084,99,1.32 [0.85-2.06],0.2202826258574717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,9173,103,0.90 [0.61-1.33],0.5964687526867836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,8064,99,0.89 [0.72-1.10],0.2873920112919808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,8037,96,0.86 [0.68-1.10],0.2285254077833682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,9245,106,0.78 [0.55-1.11],0.1670986137199764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,7799,96,0.85 [0.57-1.29],0.4514554005719069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",7875,96,0.87 [0.68-1.12],0.2862213704495863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,9015,102,0.96 [0.72-1.30],0.8134594132335242
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,9153,102,0.82 [0.65-1.05],0.113406737995604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNST,Consortin,9188,103,0.89 [0.76-1.05],0.1722811259754528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,7799,96,1.19 [0.68-2.08],0.5471680258850049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,9300,104,0.88 [0.47-1.64],0.6823160205817792
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,9268,104,0.77 [0.52-1.14],0.1845174431249286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,9199,105,0.78 [0.47-1.29],0.331110400236936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,9199,105,0.48 [0.24-0.98],0.0449593780934321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,9210,106,0.94 [0.59-1.50],0.8088447949588493
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,9168,106,1.17 [0.77-1.80],0.4594769783576915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,7852,92,1.17 [1.00-1.37],0.0466800774793507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,8064,99,0.89 [0.58-1.36],0.584496828474905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,8080,98,1.90 [0.98-3.71],0.058478681259492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,9239,102,1.31 [0.62-2.75],0.4825474448205954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,9300,104,0.59 [0.30-1.17],0.1291382413162488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,8029,98,1.10 [0.77-1.57],0.6062185044266297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,7852,92,0.97 [0.74-1.28],0.84702256490815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,7888,96,0.75 [0.58-0.96],0.0239366412376562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,8080,98,1.21 [0.52-2.81],0.6533777809991259
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,9188,103,0.80 [0.51-1.25],0.3314305260119936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,7921,94,0.94 [0.65-1.35],0.7268258237987443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,7921,97,1.02 [0.63-1.66],0.9222642271092318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,9300,104,1.58 [1.01-2.48],0.0466715929693467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,9168,106,0.74 [0.52-1.05],0.0934358410472082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,7935,94,0.97 [0.63-1.51],0.8936840245485216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,9191,106,1.27 [0.66-2.45],0.4666653264314789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,7888,96,0.84 [0.60-1.18],0.3197362207614111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,8037,96,0.89 [0.53-1.50],0.6565991283523713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,9102,105,0.88 [0.52-1.49],0.6417819323868674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,8929,102,0.81 [0.65-1.00],0.0516099952224454
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',7826,99,0.84 [0.52-1.34],0.4571996758305136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,8968,102,0.82 [0.54-1.26],0.3765208585698549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",7888,96,1.00 [0.63-1.59],0.9860759654248192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,8993,99,0.77 [0.61-0.96],0.0203040508223943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,7799,96,1.33 [0.84-2.11],0.2293111362045776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",9153,102,0.93 [0.72-1.20],0.57184509153085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,8064,99,0.89 [0.49-1.63],0.7151899712900549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,9300,104,1.09 [0.81-1.46],0.5587598069666184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,9230,106,1.07 [0.82-1.38],0.6256149687697905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,7767,94,0.93 [0.59-1.46],0.7367360744888474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,9300,104,1.28 [0.96-1.71],0.0914978038833208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,8067,99,0.48 [0.20-1.16],0.1027498378357596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,9190,100,0.71 [0.47-1.08],0.1091164159127942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,7791,95,0.95 [0.50-1.79],0.8678188149508991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,9214,105,1.58 [0.97-2.57],0.0680896497813025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",7849,98,0.91 [0.45-1.84],0.7981268423858371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,9263,106,0.81 [0.62-1.06],0.1206988183550405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,8057,97,1.05 [0.60-1.85],0.8549375668411252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,7826,99,0.77 [0.44-1.34],0.3528036490846952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,9259,104,1.05 [0.68-1.62],0.8275956799101728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,9229,104,1.00 [0.79-1.28],0.9785108632013896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,8064,99,1.00 [0.50-2.04],0.9900752779800694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,8039,97,1.09 [0.63-1.89],0.7512774845372905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,9245,106,1.21 [0.84-1.75],0.3060834783859488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,8987,101,0.92 [0.75-1.15],0.4705161913060598
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,9110,106,0.84 [0.66-1.05],0.1257562368772222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,7791,95,1.10 [0.80-1.53],0.5506413518525266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,7791,95,1.68 [0.82-3.44],0.1575747665065844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,9085,102,1.65 [1.05-2.59],0.0296967766983916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,7921,97,1.00 [0.60-1.68],0.9982961077780392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,9220,106,0.82 [0.59-1.14],0.2436299076044892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,8970,101,0.98 [0.79-1.20],0.817800010464091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,9191,106,0.82 [0.44-1.52],0.5292857050628434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,9015,102,1.02 [0.77-1.34],0.9071722582635184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,9238,106,1.17 [0.50-2.73],0.7165788933727795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,9129,106,1.57 [1.08-2.29],0.017962024410719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,9268,104,0.95 [0.73-1.24],0.7056408074187637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,8001,95,0.86 [0.42-1.76],0.6747570633142923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,9214,106,0.87 [0.74-1.02],0.0793901323098487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,9238,106,2.70 [1.32-5.53],0.006629084736243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,8963,99,1.00 [0.77-1.29],0.9947036554576482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,9300,104,0.75 [0.42-1.32],0.3196165495251172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,9129,106,1.13 [0.81-1.59],0.4691452573031842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,7852,92,1.08 [0.72-1.60],0.7189089932545453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,9015,102,0.91 [0.76-1.10],0.3306500689005358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,8064,99,0.74 [0.54-1.02],0.067861471416355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,8060,98,1.06 [0.85-1.31],0.6008993716517748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,8060,98,0.80 [0.66-0.97],0.0238608298688365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,7799,96,0.94 [0.71-1.23],0.6509070122371173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,7888,96,0.87 [0.70-1.08],0.2099603772699012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,7826,99,1.06 [0.91-1.24],0.4644081180313485
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,9238,106,1.40 [0.76-2.61],0.2826610342980643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,8070,98,1.13 [0.69-1.84],0.6311726276275335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,7826,99,1.18 [0.69-2.03],0.5484409430656323
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,9129,106,1.11 [0.85-1.46],0.4450169743207469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,7849,98,1.18 [0.75-1.86],0.4716854106606235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,9023,101,0.96 [0.66-1.39],0.8110693616342067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,7849,98,1.01 [0.53-1.94],0.9662713697716052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,8070,98,1.09 [0.55-2.16],0.8002803412759956
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,7849,98,0.96 [0.70-1.32],0.8028776270532717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,8052,99,0.69 [0.44-1.07],0.0954371912220219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,8080,98,0.72 [0.39-1.31],0.2810763381919423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,7799,96,1.07 [0.74-1.54],0.7352192078384461
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,7826,99,1.00 [0.82-1.23],0.9672649144877584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,7027,84,1.08 [0.88-1.32],0.475808314326033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,9231,106,1.43 [0.80-2.56],0.2277596029857338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,9036,106,1.09 [0.80-1.48],0.587830514722528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,8952,98,1.59 [1.10-2.29],0.0139676728625455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,9219,105,1.06 [0.89-1.26],0.5387029192829813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,9073,101,1.01 [0.65-1.56],0.9677391655352112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,7918,94,0.84 [0.56-1.27],0.4055106657482065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,7945,96,1.78 [0.84-3.79],0.1318021607452183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,9015,102,0.82 [0.66-1.02],0.0803838408588506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,8080,98,1.46 [0.78-2.75],0.2397411168438329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,8080,98,1.01 [0.52-1.93],0.9863707077314456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,7799,96,1.03 [0.62-1.73],0.8992520294379108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,9199,105,1.40 [1.03-1.89],0.0320458176049902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,9200,106,1.14 [0.88-1.48],0.3259316953647509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,8060,98,0.99 [0.75-1.31],0.9469690009783036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,9215,101,0.97 [0.70-1.35],0.8726073974576898
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,9182,105,0.76 [0.50-1.15],0.1977503576486903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,8625,98,0.92 [0.58-1.44],0.702471171349026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,7921,97,1.32 [0.91-1.92],0.1464217690481397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,9229,104,1.05 [0.67-1.63],0.8319010458317291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,8992,102,0.88 [0.69-1.12],0.289882243315667
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,9188,103,1.21 [0.59-2.47],0.5996991246659024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,9284,105,1.35 [0.77-2.38],0.2927450610239165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,7157,82,1.99 [0.85-4.68],0.1153236548860057
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,9240,102,1.21 [0.81-1.80],0.3503053044366092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,9224,106,1.39 [0.82-2.36],0.2275885305269281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,7852,92,0.93 [0.52-1.66],0.8068072649550669
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,7974,97,1.04 [0.76-1.42],0.8113574948237294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,9129,106,1.03 [0.62-1.71],0.8981792689228854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,9168,106,0.91 [0.65-1.27],0.5752560296851043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,9193,104,0.91 [0.75-1.09],0.3002533742649564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,9238,106,1.04 [0.81-1.34],0.7592546046550994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,9263,106,1.05 [0.85-1.30],0.6312607138282142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,9023,101,1.11 [0.72-1.71],0.6389625372744507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,9263,106,1.09 [0.86-1.37],0.4823821371135697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,9023,101,0.78 [0.55-1.13],0.1905062608826547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,9290,103,0.61 [0.29-1.28],0.1936673837431246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,9284,105,1.49 [0.98-2.27],0.05979059964246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,9201,105,0.81 [0.68-0.96],0.0184512385063237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,9162,103,0.91 [0.78-1.05],0.2027409273953552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,9284,105,1.00 [0.80-1.24],0.9774530405940248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,9126,103,0.73 [0.55-0.97],0.0318182990372129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,9238,106,0.95 [0.73-1.23],0.6902090114312796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,7791,95,0.97 [0.74-1.26],0.8024951250406014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,7935,97,0.91 [0.64-1.31],0.6191424103470831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",7826,99,0.96 [0.76-1.21],0.7196051251488409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,7791,95,1.05 [0.81-1.37],0.695612853000793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,8080,98,1.63 [0.73-3.62],0.2344339930441296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,7921,97,0.92 [0.72-1.16],0.4791316905513595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,9268,104,0.90 [0.77-1.05],0.1627043175875256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,9238,106,0.68 [0.46-1.00],0.0495148375983233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,7849,98,1.02 [0.73-1.43],0.8935525539905916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,7849,98,0.76 [0.51-1.14],0.1898176842004717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,9168,106,0.84 [0.74-0.96],0.0097846126679438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",9110,106,0.87 [0.69-1.10],0.2370814490706506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,8049,97,1.03 [0.85-1.25],0.7410842183384201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,9159,102,0.81 [0.64-1.03],0.0895500250471043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,7849,98,0.95 [0.64-1.43],0.8209229231081142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,9238,106,0.86 [0.72-1.04],0.120878522810863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",9229,104,0.67 [0.41-1.09],0.1040809245459791
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,7852,92,0.86 [0.35-2.11],0.7408801540268695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,7791,95,1.02 [0.75-1.38],0.9132588437364154
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,7791,95,1.53 [0.85-2.73],0.1533406662434215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCN,Decorin,9015,102,0.55 [0.26-1.20],0.1355946288839153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,7921,97,0.84 [0.68-1.03],0.091252319994161
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,9268,104,0.87 [0.67-1.13],0.3055898555619687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,9153,102,0.90 [0.74-1.09],0.2602013092114926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,8968,102,0.96 [0.75-1.23],0.7513152516993845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,9188,103,0.95 [0.53-1.68],0.8465442134963486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,7799,96,1.06 [0.83-1.36],0.6267844399207463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,7791,95,1.08 [0.87-1.35],0.4647717691580389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,9229,104,0.87 [0.62-1.22],0.4280428925455343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,7826,99,1.01 [0.64-1.61],0.962986693922973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",9153,102,0.71 [0.46-1.08],0.1115307249899388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,9172,103,0.67 [0.47-0.97],0.0340763400608033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,8052,99,0.87 [0.65-1.17],0.3645312605524095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,7921,97,0.94 [0.74-1.20],0.6407994834224104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,9263,106,1.20 [0.56-2.55],0.6431629428512335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,8080,98,1.19 [0.76-1.86],0.4388014806585788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,8029,98,0.98 [0.66-1.44],0.8990536751023812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,7852,92,1.16 [0.72-1.87],0.5387511557811013
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,7849,98,0.91 [0.38-2.19],0.8419491581983207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,7849,98,1.03 [0.72-1.47],0.8842264158557137
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,7852,92,1.63 [1.00-2.68],0.052097545237512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,8987,101,0.91 [0.65-1.27],0.5797325599787442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",9168,106,0.86 [0.72-1.03],0.1015482319680219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,9025,101,1.03 [0.74-1.42],0.8827708432150202
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,7780,97,0.95 [0.57-1.59],0.8488811119668829
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,7799,96,0.96 [0.66-1.41],0.8523982717459926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,7799,96,1.00 [0.78-1.28],0.986006618235433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,7799,96,1.02 [0.74-1.41],0.9042344302854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,9076,100,1.02 [0.91-1.15],0.7273040159641135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,7826,99,1.19 [0.89-1.61],0.2453816760512933
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,7849,98,0.84 [0.58-1.22],0.3562763193300601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,9284,105,0.77 [0.59-1.01],0.0590041427370783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,7799,96,1.19 [0.84-1.69],0.3204578970929432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,7849,98,0.84 [0.57-1.22],0.3488471606725902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,9023,101,0.80 [0.47-1.34],0.389826644664349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,7826,99,0.81 [0.52-1.26],0.3502131684958558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,8037,96,1.09 [0.71-1.67],0.6935187198348294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,8060,98,0.85 [0.54-1.34],0.4820384421231523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",9170,102,0.86 [0.73-1.01],0.0597705122242437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,7852,92,1.30 [0.90-1.90],0.1656716835476054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,7921,97,0.94 [0.45-1.96],0.8606231276446891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,9263,106,0.94 [0.71-1.26],0.6983208370300176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,9300,104,0.90 [0.51-1.61],0.7273350620698895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,9121,106,1.56 [1.12-2.20],0.0095387116233937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,9153,102,1.03 [0.85-1.26],0.7445966303337987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,8060,98,1.05 [0.80-1.38],0.7318848698140596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,8052,99,0.76 [0.48-1.21],0.2461394073345449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,9300,104,1.10 [0.79-1.51],0.5812556291963565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,9229,104,1.21 [0.68-2.13],0.5154302057507383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,7888,96,0.86 [0.62-1.19],0.3712120621520786
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,7888,96,1.05 [0.71-1.54],0.8077675971411973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,7888,96,0.98 [0.72-1.33],0.8928870084429769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,7791,95,1.48 [1.09-2.02],0.0125740381169834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,9265,104,0.84 [0.68-1.04],0.1171974499039445
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,8060,98,1.09 [0.84-1.41],0.530097460381235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,9153,102,0.95 [0.78-1.17],0.6503523766911162
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,8029,98,0.69 [0.49-0.95],0.0234165007333494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,7921,97,0.93 [0.64-1.33],0.6773749536438298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,7844,94,0.83 [0.65-1.05],0.1214962063259638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,9015,102,1.07 [0.81-1.41],0.6564179151713723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,8060,98,0.84 [0.49-1.42],0.505762427689268
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,7888,96,0.92 [0.73-1.18],0.5199273893747728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,8029,98,0.86 [0.66-1.11],0.2377742611537755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,9179,105,0.76 [0.37-1.54],0.4418505788363364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,7799,96,0.96 [0.77-1.19],0.6977027650764895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,8029,98,0.84 [0.71-0.99],0.0370716908270003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,8052,99,1.12 [0.79-1.58],0.52318339143928
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,9129,106,0.93 [0.69-1.25],0.6324516760566882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,8060,98,0.95 [0.68-1.34],0.7865048529087121
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,9232,106,0.85 [0.61-1.18],0.3231390892467584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,7852,92,0.93 [0.52-1.66],0.8089009694925559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,7799,96,1.09 [0.94-1.26],0.2465075429365092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,8060,98,0.89 [0.77-1.02],0.1026736214519974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,9188,103,0.90 [0.78-1.04],0.1632274012050399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,9110,106,0.92 [0.66-1.28],0.6003046265726274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,9153,102,0.68 [0.36-1.28],0.2336341704860505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,9168,106,0.95 [0.57-1.56],0.8253154063922772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,9055,105,0.53 [0.29-0.97],0.0385966037334543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,9153,102,1.06 [0.62-1.80],0.8266313090495354
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,9115,103,0.97 [0.72-1.31],0.8426632518129789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,9300,104,0.59 [0.31-1.12],0.1082652266241541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,9234,103,0.89 [0.66-1.22],0.4720808878441213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,9129,106,1.06 [0.71-1.57],0.7762361720037128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,9153,102,0.84 [0.61-1.16],0.2990295501368122
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,9102,104,0.92 [0.55-1.55],0.7518228019636374
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,8052,99,1.24 [0.72-2.15],0.4364673146432228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,9199,105,0.56 [0.30-1.07],0.0788316314775341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,9238,103,1.55 [0.92-2.61],0.0972261649969897
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,9127,102,1.38 [0.98-1.94],0.0664617363151001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,7921,97,0.85 [0.67-1.07],0.1559197672556263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,8023,96,1.10 [0.68-1.77],0.709389786894079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,7852,92,1.21 [0.92-1.59],0.1693645443911062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,9153,102,1.13 [0.54-2.37],0.7372131285408399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,8064,99,0.96 [0.72-1.27],0.7776342442431611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,9015,102,1.10 [0.88-1.37],0.3919647855498923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,8037,96,1.21 [0.78-1.86],0.3906653308328127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,7852,92,0.92 [0.67-1.28],0.6339060741516789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,8968,102,0.96 [0.78-1.18],0.6850646071792639
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",8029,98,0.90 [0.74-1.09],0.2807174490884758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,8060,98,0.73 [0.47-1.14],0.1617417026155478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,8037,96,0.99 [0.65-1.52],0.9805598868627392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,7852,92,1.08 [0.85-1.37],0.5216354850861704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,8037,96,0.90 [0.57-1.41],0.6408715768207018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,9129,106,0.88 [0.73-1.05],0.159831194452212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,9249,103,0.70 [0.39-1.26],0.2371866883366702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,8968,102,0.78 [0.47-1.30],0.3381739547786323
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",8064,99,0.99 [0.76-1.29],0.9443228496064257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",7888,96,0.85 [0.69-1.05],0.1397445756445163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,7826,99,1.03 [0.75-1.41],0.8558030188273849
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,7861,95,1.32 [0.75-2.31],0.3297286836996787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,7799,96,1.20 [0.88-1.62],0.2507919225585194
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,9268,104,0.93 [0.58-1.49],0.7613144208240362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,9168,106,0.85 [0.70-1.02],0.0876603898979428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,8037,96,1.05 [0.67-1.65],0.8338786812930602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,7826,99,1.32 [0.85-2.05],0.2109464557994057
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,8052,99,0.79 [0.57-1.10],0.1673063082901717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,9015,102,0.75 [0.44-1.30],0.3036772702096917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,7888,96,2.58 [1.36-4.89],0.0038244209690589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,7849,98,1.32 [0.93-1.86],0.1208089218118446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,8064,99,0.87 [0.70-1.08],0.2140341357828178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,8029,98,1.53 [0.82-2.88],0.1841198953657117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,7935,94,1.09 [0.62-1.92],0.7563794169278899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,9235,105,0.59 [0.34-1.04],0.0701821290126832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,8052,99,1.70 [1.08-2.67],0.0226339655922019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,9188,105,1.08 [0.58-2.01],0.7980352132845212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,9115,106,1.52 [0.89-2.61],0.1270089145600865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,7852,92,1.14 [0.82-1.58],0.4452704297618091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,9187,106,0.89 [0.75-1.05],0.1635662842656284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,8987,101,1.51 [1.06-2.14],0.0221146466577688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,8029,98,1.06 [0.56-2.01],0.8486171513167888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,9300,104,0.49 [0.17-1.44],0.1924878852264828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,9168,106,0.81 [0.57-1.17],0.2613010366606511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,8064,99,0.87 [0.67-1.14],0.310561584340387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,7888,96,0.91 [0.77-1.08],0.2882254141078852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",8060,98,1.25 [0.92-1.69],0.1539059873550342
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",7990,96,0.93 [0.77-1.12],0.4469295280848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,7826,99,0.83 [0.61-1.14],0.2568166987317649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,7888,96,1.30 [0.84-2.01],0.2373521429061641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,9129,106,0.85 [0.63-1.13],0.2546025012675693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,7849,98,0.89 [0.71-1.11],0.3041982064069778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,9188,103,0.97 [0.74-1.27],0.8274293333733094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,9284,105,0.88 [0.74-1.05],0.1431086103941719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,8052,99,0.95 [0.71-1.29],0.7565796819803664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,7826,99,0.75 [0.46-1.22],0.2468576385793529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,9023,101,1.01 [0.53-1.94],0.9746436133944985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,8052,99,0.93 [0.74-1.16],0.5124026729045198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,7799,96,1.14 [0.92-1.42],0.2346129428641047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELN,Elastin,8064,99,1.00 [0.59-1.70],0.9873385605284476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,9153,102,0.84 [0.58-1.21],0.3493224835638719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,7826,99,1.05 [0.64-1.71],0.8592402856669887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,9023,101,1.05 [0.72-1.53],0.7934305367467295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,7436,94,1.40 [0.99-1.99],0.0584888597623736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,9300,104,1.20 [0.44-3.26],0.7247140834632848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,9180,104,0.75 [0.60-0.94],0.0103970577663528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,9263,106,0.80 [0.61-1.04],0.0960035808964756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,7888,96,1.25 [0.90-1.73],0.1858650872759045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,8037,96,0.90 [0.60-1.37],0.6383204608784969
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,7826,99,1.02 [0.51-2.05],0.9588588741273748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,7826,99,0.88 [0.55-1.42],0.6091088727136686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,9300,104,1.39 [0.79-2.47],0.2564208011633719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,9238,106,1.16 [0.74-1.81],0.5266875374507836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,7888,96,0.63 [0.37-1.06],0.0788408696348778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,8884,101,0.96 [0.78-1.18],0.6972462193438895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,8037,96,0.91 [0.61-1.34],0.6217456040849978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,8987,101,1.30 [0.92-1.84],0.1302174838078668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,9015,102,0.40 [0.18-0.91],0.0293644703951446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,9015,102,1.23 [0.62-2.42],0.5592156512696995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,7888,96,0.81 [0.56-1.18],0.2720515306043179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,7849,98,0.96 [0.51-1.77],0.8843378560285472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,7852,92,0.90 [0.64-1.27],0.5550771825912377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,9192,106,0.89 [0.75-1.06],0.204211564017546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,8037,96,1.43 [1.07-1.93],0.0173743511825129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,9232,106,1.52 [0.90-2.56],0.1175530285041413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,8968,102,1.14 [0.92-1.43],0.237919072142698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,8862,99,0.75 [0.41-1.36],0.336137707027506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,7921,97,1.25 [0.63-2.48],0.5175004159175245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,9300,104,1.05 [0.52-2.10],0.8881446686949717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,9110,106,1.12 [0.65-1.91],0.6896629860775234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,9015,102,0.94 [0.70-1.27],0.7028883271753481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,7935,94,1.30 [0.91-1.87],0.1536447389712061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,9168,106,1.27 [1.03-1.55],0.021688444919042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,7888,96,0.96 [0.73-1.28],0.8020468822190893
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,9253,104,0.99 [0.55-1.78],0.972616071687266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,9229,104,1.40 [0.67-2.91],0.3669034024046175
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,9183,105,0.89 [0.35-2.28],0.8156155124674781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,9229,104,0.51 [0.25-1.03],0.0614264645298819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,9153,102,0.89 [0.75-1.06],0.1897668850973726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,7852,92,0.81 [0.59-1.12],0.2100943485791103
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,7791,95,1.23 [0.73-2.08],0.4319360443812461
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,9110,106,0.96 [0.77-1.20],0.7467516211052031
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,7935,94,1.13 [0.63-2.01],0.6899074000328234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,7849,98,1.33 [0.86-2.05],0.1996700678922475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,8037,96,1.23 [0.78-1.92],0.3712143578006324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,7921,97,0.86 [0.73-1.02],0.077733120688712
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,9132,102,0.93 [0.46-1.85],0.8268540089978301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,7826,99,0.84 [0.52-1.34],0.4604392775619753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,9300,104,0.77 [0.44-1.34],0.3519917831288928
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,9191,106,0.63 [0.38-1.05],0.0749333314918891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,7791,95,1.17 [0.87-1.59],0.3050440418851158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,7849,98,1.24 [0.93-1.65],0.1388256932971036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,8060,98,0.93 [0.73-1.19],0.55638940716942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,7791,95,1.12 [0.70-1.79],0.6306072846414823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,7849,98,0.91 [0.73-1.13],0.3998869557461449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,7935,94,1.15 [0.68-1.94],0.5976304885244073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,7826,99,1.11 [0.82-1.49],0.5053003737003803
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,7826,99,1.10 [0.75-1.61],0.6223684650788629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,9263,106,0.70 [0.33-1.49],0.352204150026681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,8070,98,0.59 [0.30-1.17],0.1323834438544188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,7965,97,0.96 [0.49-1.88],0.8975016330389666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,9199,105,0.80 [0.58-1.10],0.1758460952329407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,8084,99,0.84 [0.53-1.31],0.4337621253113067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,8033,98,1.00 [0.46-2.15],0.9983787737152102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,8084,99,0.95 [0.27-3.32],0.93161174709494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,9220,106,0.75 [0.55-1.02],0.0701369500385853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,9218,103,0.52 [0.27-0.99],0.044970088865353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,9236,106,0.73 [0.41-1.28],0.2669704362279183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,9226,106,0.94 [0.35-2.51],0.9000305962079147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",9191,106,0.95 [0.79-1.15],0.6262884566828752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",9188,103,0.88 [0.70-1.12],0.2974958341411304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",8064,99,1.15 [0.78-1.67],0.4816041179245696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",9300,104,1.25 [0.90-1.72],0.1861150243005019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,9231,105,1.00 [0.77-1.29],0.9934446201973696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,8999,102,0.79 [0.56-1.10],0.1601409042949737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,9168,106,1.19 [0.88-1.62],0.261246938140196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,9188,103,0.79 [0.62-1.00],0.0498500084228975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,8029,98,0.90 [0.66-1.21],0.4798967912117543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,8052,99,0.94 [0.83-1.07],0.3277249273826848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,8037,96,1.34 [0.74-2.43],0.3401523806518168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,7888,96,0.88 [0.63-1.22],0.4368348686334817
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,8064,99,1.20 [0.60-2.40],0.6048427369819558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,9153,102,1.20 [0.72-1.99],0.4876933391048123
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,9172,103,1.45 [0.82-2.56],0.2008168785213553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,8029,98,1.07 [0.85-1.35],0.547185486656217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,9300,104,0.81 [0.43-1.55],0.5243024423592102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,7852,92,1.03 [0.78-1.36],0.8382084770014074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,9281,103,0.87 [0.48-1.56],0.638854208075427
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,9284,105,1.48 [0.93-2.36],0.0974005864573225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,8080,98,0.95 [0.52-1.73],0.8734741392435675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,7852,92,0.87 [0.62-1.21],0.4053384517065058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",9188,103,0.86 [0.68-1.09],0.2215387242287046
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,8064,99,1.17 [0.90-1.52],0.2459917924914356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,9168,106,0.76 [0.53-1.10],0.1465323988073846
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,8052,99,1.09 [0.50-2.40],0.821954209726583
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,9199,105,0.84 [0.58-1.21],0.3457245844488228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,9173,105,0.86 [0.67-1.11],0.2432866953319554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,8987,101,1.18 [0.88-1.59],0.2789054486162971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,9221,106,0.94 [0.67-1.32],0.7346074994454284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,8049,97,1.26 [0.86-1.84],0.229924378228932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,9162,106,0.90 [0.59-1.37],0.6227931251801303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,9188,103,1.31 [0.88-1.95],0.1832562273581146
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,9240,105,1.27 [0.91-1.79],0.1654361972339385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,9023,101,1.19 [0.87-1.63],0.2787618786414503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,9199,105,0.97 [0.71-1.31],0.826692529084081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,9168,106,0.99 [0.78-1.27],0.9661323545479644
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,8987,101,1.04 [0.77-1.39],0.8106312748882035
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",7826,99,1.05 [0.78-1.41],0.7705119995714731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",7826,99,0.83 [0.57-1.20],0.3184346448447211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,8987,101,0.95 [0.71-1.26],0.716339905489922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,8987,101,0.63 [0.41-0.96],0.0330811308078408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,9226,106,1.99 [1.11-3.54],0.0200765381988212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,7896,97,1.23 [0.65-2.34],0.5187965765932568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",8052,99,0.91 [0.71-1.17],0.4806807254625069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,7849,98,1.24 [0.94-1.65],0.1297011203529526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,7849,98,0.95 [0.62-1.45],0.8130292600895086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,9238,106,0.92 [0.73-1.14],0.4394532558993168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,9168,106,0.83 [0.63-1.08],0.1718509025238484
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,7849,98,0.66 [0.38-1.16],0.1512845125720404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,9249,103,1.02 [0.88-1.18],0.8185090555697163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,9254,103,1.38 [1.07-1.79],0.0128669294808306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,7849,98,1.08 [0.57-2.05],0.8194468860552351
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,9023,101,1.08 [0.63-1.86],0.7774979035185929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,7849,98,0.83 [0.48-1.42],0.4920689959248445
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,7791,95,0.95 [0.73-1.23],0.7001869599828037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,7776,95,0.99 [0.61-1.59],0.9571077616238344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,9229,104,1.02 [0.59-1.77],0.9413192161496364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,8080,98,1.19 [0.82-1.73],0.3606148361793586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,8060,98,0.87 [0.51-1.49],0.6187743785417404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,9229,104,2.15 [1.01-4.54],0.0459077913430871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,7921,97,0.98 [0.68-1.42],0.9218812037891148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,8070,98,0.71 [0.53-0.95],0.0204742800776456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,8968,102,0.91 [0.66-1.25],0.5455303846198061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",7799,96,1.00 [0.79-1.27],0.981379123810148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,7826,99,0.90 [0.59-1.37],0.6225684538103025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,8968,102,0.84 [0.66-1.06],0.1446412358602655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,9213,105,0.73 [0.57-0.92],0.0086479547133038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,8052,99,0.85 [0.70-1.04],0.1081776617242618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,9212,103,0.87 [0.74-1.02],0.0806439217850522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,9129,106,0.85 [0.57-1.25],0.4079926815001961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,9129,106,0.85 [0.71-1.02],0.0816274562238577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,8949,102,0.83 [0.54-1.26],0.375149243292687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,8029,98,0.90 [0.64-1.26],0.5263094165986665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,8987,101,0.92 [0.78-1.08],0.2958855959235879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,9129,106,1.17 [0.63-2.15],0.6258417075091197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,9141,102,1.16 [0.49-2.72],0.7358556690331033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,8987,101,1.02 [0.58-1.80],0.9463248225255196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,9284,105,1.27 [0.75-2.16],0.3802927206351901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,9229,104,0.96 [0.56-1.62],0.8665149784229496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,8968,102,0.90 [0.66-1.21],0.4801563700097219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,8987,101,0.98 [0.59-1.64],0.9399939540744388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,8084,99,1.48 [0.72-3.03],0.2829993309789853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,8060,98,0.93 [0.61-1.41],0.7200308565278316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,8037,96,1.01 [0.58-1.78],0.9666324472751996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,7849,98,1.08 [0.91-1.29],0.3655344507771495
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,9191,103,1.08 [0.59-1.97],0.8079686419871155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,9263,106,0.95 [0.53-1.71],0.8714642245272421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,9200,104,0.92 [0.82-1.03],0.1415129483023608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,7776,95,1.58 [0.98-2.55],0.0600981733677023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,8968,102,1.12 [0.74-1.68],0.6002691110369154
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,7849,98,0.73 [0.44-1.20],0.2083518810590037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,9168,106,0.81 [0.65-1.00],0.0462500903527267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,8987,101,1.02 [0.84-1.23],0.861214263525278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,7826,99,0.90 [0.67-1.21],0.4855642365059378
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,7852,92,1.39 [0.80-2.41],0.2431584460743933
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,9099,106,2.43 [1.17-5.03],0.0168639848675284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,7888,96,0.99 [0.71-1.39],0.9744369757543746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FST,Follistatin,9220,106,0.80 [0.56-1.15],0.2261113924403993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,7888,96,0.90 [0.36-2.20],0.8101236762589445
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,9178,105,1.45 [0.87-2.44],0.155895664123797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,8046,98,1.15 [0.93-1.41],0.1913535083829776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,9259,104,0.84 [0.69-1.02],0.0743879510388643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,7921,97,1.10 [0.81-1.48],0.5501844843313439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FURIN,Furin,9229,104,1.35 [0.80-2.27],0.2601685164358917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,8974,100,0.74 [0.46-1.19],0.2193018575524393
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",7914,94,1.07 [0.80-1.44],0.633338741113133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,9263,106,0.74 [0.51-1.08],0.118218452878068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",9129,106,1.08 [0.80-1.44],0.6256460622135771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",9268,104,0.76 [0.60-0.97],0.0252635478574687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,9023,101,0.88 [0.66-1.18],0.3962558193178772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,9184,104,0.84 [0.69-1.01],0.0653434907932912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,7852,92,1.17 [0.88-1.55],0.2930064693633277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,7799,96,0.86 [0.53-1.41],0.5518641189733757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,8037,96,1.08 [0.74-1.57],0.7012191346093299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,7935,94,1.12 [0.85-1.47],0.4119632312377695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,7799,96,0.86 [0.60-1.22],0.3889986341392909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,7791,95,2.29 [1.09-4.79],0.0288476158447921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,7849,98,1.28 [0.93-1.75],0.1328834988267411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,7935,94,1.10 [0.78-1.57],0.5825942090048447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,7888,96,0.88 [0.60-1.30],0.5315155123487225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,7791,95,1.30 [1.05-1.62],0.0173318062764632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,9238,106,1.16 [0.88-1.53],0.2864872165041755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,9153,102,0.88 [0.46-1.68],0.6916066827818654
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,9268,104,1.60 [0.84-3.07],0.1527092958273388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,9023,101,1.27 [0.84-1.94],0.2564629031160201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,8064,99,1.01 [0.52-1.98],0.9686924684973586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,9153,102,1.00 [0.43-2.29],0.9913091047246352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,7826,99,1.36 [0.96-1.92],0.0792855143755631
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,7747,92,0.92 [0.51-1.66],0.7738502488288516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,8052,99,1.50 [0.83-2.74],0.1827545180675858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,7935,94,0.98 [0.66-1.46],0.9301328259840924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,9250,102,0.78 [0.39-1.56],0.4770449810310806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,7826,99,1.50 [0.97-2.32],0.065859505361199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,8060,98,0.97 [0.85-1.10],0.6102396622244918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,7791,95,0.82 [0.39-1.74],0.6067532098549246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",7888,96,0.89 [0.69-1.17],0.4083572053318072
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,7852,92,1.02 [0.70-1.49],0.9219034055837776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,8046,98,0.96 [0.72-1.29],0.7990030827197786
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,9023,101,0.67 [0.49-0.92],0.0126343437934843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,8968,102,1.26 [0.91-1.75],0.1672053063972593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,7826,99,1.10 [0.75-1.60],0.6232049523571352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,8084,99,1.00 [0.48-2.09],0.9900612140727696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,8060,98,0.89 [0.74-1.06],0.1917954115927759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,8987,101,1.13 [0.99-1.30],0.0762837151694275
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,7740,94,1.05 [0.70-1.58],0.8003213772821033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,7826,99,0.81 [0.52-1.27],0.3606892638012201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",9153,102,1.59 [0.97-2.61],0.0686711706222539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,9300,104,0.95 [0.63-1.42],0.7901028801685784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,9188,103,0.63 [0.39-1.04],0.0695584385020353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,8968,102,1.25 [0.80-1.96],0.3217185324005333
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,8064,99,1.05 [0.74-1.47],0.798328527546474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,8967,101,0.96 [0.67-1.38],0.8197827037475375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,8987,101,0.90 [0.67-1.20],0.4696359363778136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,8987,101,0.97 [0.83-1.12],0.6528266066293685
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,9249,103,0.75 [0.41-1.39],0.364409389576753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,9153,102,1.03 [0.45-2.34],0.9522031007248374
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,9105,106,1.81 [1.03-3.15],0.0377465928475716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,7817,96,0.85 [0.61-1.18],0.3423668060031709
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,8968,102,0.80 [0.58-1.11],0.1814949685162801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,8064,99,0.79 [0.60-1.05],0.1027125836711073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,8041,98,0.71 [0.47-1.09],0.1140634674897255
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,9072,105,1.20 [0.73-1.97],0.4666056437001883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,9188,105,1.08 [0.77-1.51],0.6681506067183409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,9129,106,1.50 [0.72-3.10],0.2790753819203416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,9172,103,0.96 [0.86-1.07],0.466976878440078
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,8987,101,1.07 [0.97-1.17],0.1539114128434195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,7921,97,2.90 [1.40-6.01],0.0042266426676574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,8968,102,0.80 [0.55-1.16],0.2393872615166262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,9188,103,0.97 [0.78-1.19],0.7474916911594232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,8052,99,0.91 [0.49-1.68],0.7535397025248283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,8052,99,0.96 [0.73-1.25],0.7424171119914205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,7921,97,0.54 [0.28-1.06],0.0744443716693545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,7791,95,1.23 [0.91-1.65],0.1756128922665761
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,7888,96,1.00 [0.73-1.39],0.9848014008239984
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,8060,98,0.99 [0.52-1.90],0.9834757525636932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,8029,98,0.82 [0.68-0.99],0.0435319024056702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,7849,98,0.69 [0.43-1.13],0.1393181703489631
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,7849,98,0.89 [0.72-1.09],0.267460976770895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,7791,95,0.98 [0.72-1.33],0.8866468381202467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,8800,101,1.00 [0.52-1.93],0.989812605624935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,7907,97,1.11 [0.65-1.90],0.7023717136382858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,9129,106,0.90 [0.58-1.39],0.6369543616580285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,7849,98,1.26 [0.73-2.18],0.4005241937241596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,9015,102,1.09 [0.81-1.46],0.5764276004502996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,9195,105,0.71 [0.44-1.15],0.1638145682893851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,7799,96,1.32 [0.86-2.03],0.2110120126982811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,9114,102,1.03 [0.76-1.40],0.8650600374917193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",7921,97,0.75 [0.59-0.94],0.0136308142747737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,8968,102,1.26 [0.93-1.71],0.1402921895070045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,8037,96,0.84 [0.57-1.24],0.3842583810371413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,7868,96,1.17 [0.79-1.73],0.4284395363525652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,8064,99,0.80 [0.61-1.05],0.103333425551144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,9284,105,0.92 [0.66-1.28],0.6314396676808509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,7921,97,0.93 [0.70-1.25],0.6395364349154744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,8052,99,1.19 [0.98-1.45],0.0758506110091101
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,8987,101,0.79 [0.59-1.05],0.1023088251760992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,7852,92,0.99 [0.67-1.46],0.9666251212104664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,9199,105,1.03 [0.74-1.44],0.8424940305978317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,7888,96,1.14 [0.65-2.01],0.6393036139307713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,7921,97,0.61 [0.35-1.06],0.0798711659751315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,8052,99,1.08 [0.84-1.37],0.5576476856410978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,9263,106,0.98 [0.45-2.12],0.9495167978535936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,9168,106,0.85 [0.72-1.01],0.0679526717878469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,8029,98,1.02 [0.67-1.54],0.9426394855788676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",8080,98,0.76 [0.46-1.26],0.2882666797105485
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,9156,106,0.60 [0.34-1.05],0.0711028881033098
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,7826,99,0.94 [0.70-1.26],0.6803612769749297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,8912,100,1.02 [0.83-1.25],0.8444669259268047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,7921,97,0.86 [0.49-1.49],0.5786936701696914
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,9184,104,0.78 [0.64-0.95],0.0152861333455453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,9153,102,0.98 [0.87-1.11],0.7810356457331062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,9268,104,1.00 [0.56-1.78],0.9924592513191076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,9129,106,1.14 [0.84-1.54],0.4175405375758699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,8037,96,1.46 [1.04-2.05],0.0271375157191354
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,8029,98,1.25 [0.89-1.75],0.1993279755805517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,8070,98,0.72 [0.47-1.12],0.1467784696358545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,8029,98,0.92 [0.70-1.21],0.5448910926934907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,8968,102,0.54 [0.25-1.15],0.108939808861705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,8930,99,0.67 [0.36-1.27],0.2212617293543385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,7799,96,1.05 [0.77-1.45],0.7415688897897833
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,8052,99,1.42 [0.91-2.21],0.1240438171923912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,8029,98,1.16 [0.84-1.59],0.3754818002273379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,9015,102,1.42 [1.10-1.83],0.0078495777680752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,8037,96,1.09 [0.78-1.52],0.6155864595003269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,9188,103,0.90 [0.79-1.04],0.1502075354766724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,8064,99,0.81 [0.60-1.10],0.180286745333337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",8052,99,1.32 [0.93-1.89],0.1208907226246333
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",7799,96,1.01 [0.71-1.43],0.965270831201966
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,9015,102,1.11 [0.80-1.55],0.5237684456463023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,9163,103,0.99 [0.47-2.08],0.9825131538550091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,7888,96,1.46 [1.05-2.05],0.026517337337876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",9153,102,0.71 [0.51-0.99],0.0458027440479543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,7745,95,0.94 [0.73-1.21],0.6154231603655667
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,8987,101,0.84 [0.65-1.09],0.2010913852091825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,8045,98,1.13 [0.40-3.19],0.8162925691287597
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",8022,95,0.95 [0.38-2.37],0.9048538720564452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,9171,103,1.12 [0.92-1.36],0.2620380755625525
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,8987,101,1.23 [1.00-1.51],0.0454773425857781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,7826,99,1.12 [0.88-1.41],0.3685188022147624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,8913,101,0.91 [0.69-1.19],0.4821509998416475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,8060,98,1.05 [0.97-1.14],0.2506414467546389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,7935,94,1.25 [1.02-1.54],0.0302977004713149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,7852,92,0.82 [0.63-1.06],0.1309927057188333
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,9153,104,0.94 [0.56-1.56],0.7983178225541496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,7935,94,1.19 [0.97-1.46],0.0898781024000444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,7826,99,0.98 [0.58-1.67],0.953942429383432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,9251,103,0.99 [0.76-1.31],0.9704800011668704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",9015,102,0.83 [0.68-1.00],0.0553949838324778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,9284,105,1.06 [0.65-1.70],0.8264740143153488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,9168,106,0.92 [0.69-1.21],0.5396445242117257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,9015,102,0.96 [0.75-1.22],0.7364500957631215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,7791,95,0.90 [0.58-1.40],0.654392551413397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",7826,99,1.06 [0.82-1.37],0.6718045043806873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",9232,103,1.09 [0.87-1.37],0.4569531993440361
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,9268,104,0.91 [0.79-1.05],0.1874552878598364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",9199,105,0.78 [0.62-0.98],0.0326233260672086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,9251,104,0.95 [0.72-1.25],0.7320413366469235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,9199,105,0.89 [0.55-1.46],0.6570124706041957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,9232,103,1.02 [0.80-1.30],0.8636218110485876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,9268,104,1.11 [0.84-1.47],0.4641778149139708
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,8064,99,0.91 [0.76-1.10],0.3259880364261838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,7826,99,1.10 [0.81-1.48],0.5418543011045696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,9284,105,0.73 [0.54-1.00],0.0518509619504722
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,7849,98,1.11 [0.82-1.50],0.4837953870698371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,7799,96,0.99 [0.73-1.34],0.9481013397856354
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,8029,98,0.98 [0.63-1.52],0.9260797731605744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,9254,103,0.95 [0.79-1.14],0.5557714935560417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,8060,98,0.95 [0.70-1.30],0.7606466805060329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,9015,102,0.82 [0.58-1.17],0.2746341065569049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,7921,97,0.58 [0.28-1.23],0.1555799151317227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,8060,98,1.23 [0.77-1.98],0.3825323952587555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,8064,99,2.03 [0.94-4.40],0.0707713259172881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,9168,106,0.90 [0.73-1.12],0.3559083542633851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,9284,105,1.57 [0.97-2.55],0.0690517354120054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,7987,96,1.03 [0.51-2.08],0.9303745346216192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,8987,101,0.89 [0.71-1.13],0.346914880076676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,8060,98,0.99 [0.76-1.29],0.9358319778902364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,7849,98,1.11 [0.85-1.44],0.4519625527817793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,7826,99,1.19 [0.68-2.08],0.5365765345698684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,8041,98,0.89 [0.56-1.43],0.642286704245687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,8052,99,1.14 [0.77-1.67],0.5170239724737715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,9015,102,0.57 [0.30-1.09],0.0890696967764217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",8052,99,1.50 [0.82-2.73],0.1853209822928626
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",9145,106,1.17 [0.74-1.87],0.4991251340563823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",9168,106,1.15 [0.65-2.04],0.6251854898052758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,9268,104,1.25 [0.86-1.83],0.2415603623107793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,7908,97,1.11 [0.78-1.57],0.5661121154865854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",7888,96,0.89 [0.58-1.35],0.5721866208922567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",7826,99,1.25 [0.84-1.85],0.2702915202609505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,7777,95,1.00 [0.66-1.50],0.99707812601552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,9086,101,1.20 [0.83-1.74],0.3374645107745448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,8968,102,0.56 [0.35-0.90],0.016973436145684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,7852,92,1.03 [0.78-1.36],0.8324421846948578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,9083,106,0.93 [0.65-1.32],0.6716662013251973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,8993,101,0.88 [0.69-1.12],0.2931685522229795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,8052,99,0.83 [0.54-1.28],0.4050418092007819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,9284,105,0.76 [0.60-0.95],0.016831204421778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,8987,101,1.05 [0.65-1.69],0.8430051760499873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,7967,95,0.93 [0.75-1.15],0.4914612650496857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,7914,93,1.02 [0.85-1.23],0.8532336786171567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,7888,96,1.23 [0.75-2.04],0.4103853024117994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,8033,98,1.35 [0.73-2.50],0.3396133694331111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,7888,96,0.90 [0.71-1.13],0.3595256865358984
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,9153,102,0.90 [0.57-1.44],0.6694567298293694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,9268,104,1.61 [1.00-2.60],0.0487324102452034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,7849,98,1.64 [0.91-2.94],0.0975429428243548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,7888,96,0.91 [0.74-1.13],0.4012404458058819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,9168,106,0.66 [0.44-1.01],0.0548712434781359
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,8060,98,1.09 [0.81-1.48],0.5658490336151316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,7826,99,0.86 [0.56-1.30],0.4674505797223288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,7888,96,1.02 [0.67-1.55],0.933046748110964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,8926,101,0.98 [0.75-1.29],0.890767032640172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,9232,106,0.76 [0.59-0.98],0.0336948730390753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,8037,96,0.87 [0.47-1.62],0.658476448319973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,9052,101,0.87 [0.68-1.13],0.3029455185287719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,9268,104,1.22 [0.77-1.93],0.4049659833719961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,9146,105,1.81 [1.02-3.21],0.0436137791706373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,7799,96,1.03 [0.82-1.29],0.8289143779506953
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,7799,96,1.31 [0.91-1.88],0.1474508256612145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",9229,104,0.82 [0.61-1.10],0.1834716449645078
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,9154,105,0.84 [0.40-1.80],0.6587302999692597
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,9300,104,0.66 [0.30-1.44],0.2987461928636578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,9023,101,0.85 [0.67-1.07],0.1624887108826045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,9165,105,1.01 [0.55-1.86],0.9724713321883188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,9300,104,0.62 [0.37-1.06],0.0818579318062637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,9300,104,0.57 [0.29-1.15],0.1181205714367921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,9168,106,0.79 [0.57-1.08],0.1392100657965049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,9188,103,1.05 [0.70-1.56],0.821065892723472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,9153,102,0.78 [0.31-1.96],0.592125286724286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,7935,94,1.12 [0.74-1.69],0.5863025085250744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,8968,102,0.87 [0.59-1.29],0.4898243283376011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",7888,96,1.12 [0.84-1.49],0.4421874997838126
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,9284,105,0.28 [0.07-1.14],0.0750086975445616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,9268,104,1.55 [1.04-2.29],0.0296059414101735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,7819,96,0.88 [0.52-1.49],0.6464652259661325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,7935,94,1.06 [0.76-1.49],0.7247950956664153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,7935,94,0.92 [0.53-1.59],0.7652749234882498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,8029,98,1.47 [0.76-2.84],0.2485560416915682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,9023,101,0.93 [0.79-1.08],0.3391841872716458
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,9238,106,1.07 [0.46-2.45],0.8771428520861337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,9129,106,1.30 [0.95-1.78],0.1007674373367596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,8968,102,0.94 [0.63-1.40],0.7497143091749316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,7799,96,1.03 [0.77-1.38],0.8381242616187765
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,9168,106,1.34 [0.89-2.01],0.1589095785220313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,7826,99,0.86 [0.47-1.57],0.6289328946583331
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,7852,92,1.06 [0.67-1.69],0.8001015004060302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,8052,99,0.91 [0.66-1.26],0.5797171140897024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,7799,96,1.48 [1.12-1.97],0.0062564511559585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,8080,98,0.69 [0.33-1.45],0.3321082525673949
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,9153,102,0.82 [0.35-1.92],0.6517860181601309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,7826,99,1.00 [0.66-1.52],0.9990447682268518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,9199,105,0.67 [0.31-1.44],0.3052341103716631
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,9286,104,0.84 [0.72-0.97],0.0217310301754881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,9288,103,0.78 [0.60-1.02],0.0666726592430417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,9245,106,1.47 [0.81-2.68],0.2086091203979335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,9093,105,1.27 [0.88-1.84],0.2043708671509176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,9168,105,1.42 [0.83-2.46],0.2044069334382392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,9300,104,1.44 [0.83-2.49],0.1952813340723873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,9188,103,1.51 [0.94-2.42],0.0892240412716635
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,7849,98,1.02 [0.79-1.32],0.8919889829844199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,7826,99,1.05 [0.74-1.49],0.7796076531195357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,8064,99,1.03 [0.50-2.14],0.9364477524364148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,7791,95,0.97 [0.78-1.20],0.773744774547612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,7888,96,1.01 [0.61-1.70],0.9605035813916496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,9153,102,1.19 [0.73-1.95],0.4789597146783343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,9188,103,0.82 [0.45-1.49],0.5178290734562905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,8064,99,1.23 [0.98-1.54],0.0713578972884798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,9168,106,0.87 [0.72-1.06],0.1678681867374902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,8987,101,1.03 [0.85-1.26],0.7345024200004431
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,9023,101,1.02 [0.83-1.25],0.8836844566141755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,9023,101,0.99 [0.72-1.35],0.9366065370123412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,9238,106,1.13 [0.63-2.04],0.6742739536130975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,9023,101,1.05 [0.81-1.36],0.7189496150698971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,9153,102,1.23 [1.00-1.51],0.0539873214030461
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,9284,105,1.25 [0.91-1.70],0.1677395756879034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,9023,101,0.70 [0.43-1.13],0.1468334417008923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,7849,98,1.22 [0.78-1.90],0.3802173611809393
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,9023,101,1.11 [0.80-1.56],0.5295470346797269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,9084,101,1.81 [0.77-4.23],0.173642056497384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,7799,96,1.36 [0.71-2.60],0.3589940542645767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,9168,106,0.67 [0.40-1.15],0.1466067936126982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,9023,101,1.28 [0.77-2.11],0.3393903398798329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,9284,105,0.77 [0.50-1.20],0.2553469920337567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,9014,101,0.68 [0.43-1.08],0.1055042451804171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,9023,101,1.02 [0.81-1.30],0.8475010926090161
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,9023,101,1.53 [1.06-2.21],0.0235696171885947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,9023,101,0.94 [0.74-1.19],0.6212144655277916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,9199,105,0.94 [0.64-1.39],0.7585348695627836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,9053,105,0.72 [0.51-1.00],0.0488496964895473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,9165,106,1.13 [0.80-1.61],0.4878109185896675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,9245,106,1.02 [0.59-1.77],0.9463432071747278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,9284,105,1.11 [0.67-1.87],0.6799997490679808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,9069,106,1.03 [0.94-1.14],0.483458219598882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,8959,101,0.91 [0.70-1.18],0.47931883022039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,9023,101,1.04 [0.78-1.40],0.7903116211022359
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,8984,101,0.99 [0.73-1.35],0.9473116562759224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,9188,105,0.70 [0.33-1.47],0.3468607435806342
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,9182,106,1.33 [0.55-3.25],0.5267567347509041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,9199,105,0.82 [0.55-1.22],0.3273059758916115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,9281,103,0.99 [0.67-1.48],0.975350562832017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,9023,101,1.45 [0.91-2.33],0.1204922595663932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,9192,104,0.96 [0.71-1.31],0.8156234383670029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,9023,101,0.80 [0.46-1.40],0.4335328409417616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,9023,101,1.00 [0.72-1.38],0.9989838969728942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,9023,101,0.70 [0.43-1.14],0.1492214689397004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,7849,98,0.90 [0.56-1.46],0.6760196012752333
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,7849,98,1.07 [0.78-1.46],0.6706524336853799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,8037,96,0.94 [0.71-1.26],0.7013806106952833
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,9023,101,1.01 [0.67-1.52],0.9711079517001364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,9023,101,1.13 [0.82-1.56],0.4485663430670789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,7762,95,1.00 [0.56-1.78],0.9960130157681834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,9122,100,1.02 [0.66-1.59],0.9164464090313158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,9023,101,1.35 [0.95-1.90],0.0905753974760392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,8037,96,1.70 [1.37-2.12],2.203325217712715e-06
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,7791,95,0.89 [0.65-1.23],0.4874796721846768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,7849,98,1.18 [0.87-1.60],0.2996094732339848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,7815,98,1.42 [0.88-2.30],0.1541968220225507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,9168,106,0.58 [0.38-0.88],0.0115338309907316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,9023,101,0.75 [0.48-1.18],0.2093348284340607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,8957,102,1.39 [0.84-2.29],0.1959837079547853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,7849,98,1.01 [0.72-1.43],0.9415497627530264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,7808,97,0.99 [0.74-1.33],0.941040929365352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,9023,101,0.95 [0.55-1.64],0.8588442975377032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,9023,101,1.02 [0.83-1.24],0.8657893226058981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,9168,106,0.78 [0.47-1.28],0.3194461836809733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,9023,101,1.03 [0.92-1.16],0.595640997313134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,9168,106,0.78 [0.56-1.07],0.1219207840551336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,9153,102,1.02 [0.81-1.29],0.8472042749695092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,9150,105,0.92 [0.55-1.53],0.7473054684111509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,9188,103,0.83 [0.30-2.32],0.7244192199935281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,9168,106,0.80 [0.61-1.05],0.1095013115025398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,9199,105,0.71 [0.52-0.98],0.039151257353102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,7935,94,1.12 [0.82-1.53],0.4786975786259319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,8958,102,0.76 [0.54-1.06],0.1015692078694054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,8037,96,1.12 [0.72-1.72],0.6224756113937303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,9129,106,0.73 [0.54-0.98],0.0387125139681728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,8060,98,0.92 [0.65-1.30],0.6313954514118114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,7799,96,1.28 [0.75-2.20],0.3670637535978756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,8949,102,0.60 [0.38-0.94],0.025109804584282
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,7921,97,1.37 [0.96-1.95],0.0828948533185402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,9199,105,1.38 [0.90-2.14],0.1433177752465637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,9153,102,0.85 [0.61-1.20],0.3595743150022001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",7888,96,1.11 [0.79-1.57],0.5434267946717118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",8052,99,1.16 [0.78-1.72],0.4780276446848571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",9153,102,0.88 [0.73-1.05],0.1559165352627255
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,8060,98,0.90 [0.66-1.23],0.5212345642027048
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,8037,96,1.26 [0.91-1.74],0.1667780436398814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,8029,98,1.40 [1.17-1.67],0.0002452464510362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,7849,98,0.52 [0.16-1.65],0.2639788714789555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,9115,106,0.89 [0.73-1.08],0.2440521636494518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,9153,102,0.79 [0.56-1.11],0.1713494253905507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",9015,102,0.91 [0.74-1.13],0.398717460149363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,9023,101,0.89 [0.68-1.16],0.3926355457413467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,9168,106,0.87 [0.74-1.02],0.0819676790806715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,8852,102,1.03 [0.65-1.64],0.8978605180697075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,9168,106,1.62 [1.02-2.58],0.0415210745757173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,8080,98,1.06 [0.68-1.63],0.8041710202190825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,7965,97,0.84 [0.69-1.03],0.0889577417162757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,9168,106,0.66 [0.40-1.10],0.1120994349506421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,7921,97,0.62 [0.35-1.10],0.1051295829255823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,9199,105,0.66 [0.33-1.32],0.2394611619643129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,9168,106,0.72 [0.50-1.03],0.0728417262019926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,7849,98,1.03 [0.66-1.62],0.8870469697881823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,9199,105,0.36 [0.21-0.64],0.0004631990375371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,9268,104,0.32 [0.11-0.92],0.0338166316617825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,7935,94,0.79 [0.52-1.20],0.2623093482903764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,9205,105,0.46 [0.20-1.06],0.0685661216804305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,8987,101,1.03 [0.68-1.54],0.8963521430887369
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,9015,102,0.85 [0.73-1.00],0.04629864194578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,9137,102,0.54 [0.28-1.02],0.0580682986978741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,9229,104,0.56 [0.34-0.93],0.0238220813222257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,9023,101,0.84 [0.47-1.52],0.569456598761504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,9268,104,0.96 [0.65-1.42],0.8483985075202595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,8080,98,1.18 [0.70-1.98],0.5355225599572564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,8084,99,2.05 [0.81-5.23],0.1319325237711084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,9245,106,0.73 [0.47-1.13],0.1590731247154204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,8084,99,1.01 [0.49-2.07],0.974130025188754
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,8037,96,1.38 [0.97-1.95],0.071927269897724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,9168,106,1.22 [0.92-1.62],0.1647466069040668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,7826,99,1.00 [0.74-1.34],0.9772411965273204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",7888,96,1.00 [0.75-1.33],0.9863079884665188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",7799,96,0.85 [0.51-1.40],0.5172364935504603
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",8968,102,1.41 [1.05-1.89],0.0238858058413201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,7791,95,1.17 [0.79-1.73],0.426899627248247
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,9263,106,0.91 [0.48-1.75],0.7864514880750513
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,7921,97,0.74 [0.49-1.13],0.1652633515157595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,9023,101,1.07 [0.80-1.42],0.6544697394192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,7791,95,0.93 [0.64-1.33],0.6775568488675145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,8029,98,0.77 [0.61-0.97],0.023482212711511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,9023,101,0.92 [0.62-1.38],0.693582136181041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,9153,102,1.23 [0.82-1.85],0.3183000213749129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,8029,98,0.91 [0.76-1.10],0.3211266788410274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,7799,96,0.91 [0.62-1.33],0.6133721726353067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,7852,92,0.99 [0.76-1.29],0.9548274483483434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,8968,102,0.86 [0.57-1.30],0.4785436214433147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,7917,97,0.59 [0.35-0.98],0.0405009216226844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,7849,98,1.11 [0.92-1.35],0.2789357106346281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,9229,104,1.35 [0.66-2.78],0.4073710022509309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,8968,102,0.99 [0.61-1.62],0.9767338933309236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,7791,95,1.09 [0.84-1.42],0.5312342388510867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,7888,96,0.89 [0.65-1.22],0.4529720762778384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,8060,98,0.80 [0.41-1.53],0.4920001537544763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,7935,94,1.13 [0.87-1.47],0.3593056195634295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,7935,94,1.54 [0.85-2.80],0.1562828529531215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,8037,96,1.03 [0.74-1.43],0.8598196367558556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,7826,99,1.02 [0.60-1.74],0.9385062877328024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,7799,96,1.25 [1.03-1.53],0.027520742302585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,7826,99,1.04 [0.88-1.22],0.6737996268264563
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,9153,102,0.85 [0.69-1.04],0.1174214748599128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,8037,96,1.04 [0.84-1.30],0.6932575445040103
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,8987,101,1.12 [0.90-1.39],0.3085576902070593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,8029,98,1.01 [0.90-1.12],0.8998775815784104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,8987,101,0.98 [0.85-1.12],0.7391430446424883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,7791,95,1.00 [0.79-1.27],0.9800643594338944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,7799,96,1.21 [0.93-1.59],0.1605896952109345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,8968,102,0.98 [0.62-1.54],0.92091479405137
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,9226,106,0.71 [0.40-1.26],0.2460138126616291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,9188,103,1.35 [0.83-2.20],0.2273025224686675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,8968,102,0.76 [0.59-0.98],0.0311499659694077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,7799,96,0.76 [0.45-1.30],0.3216499020476756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,8052,99,1.03 [0.68-1.57],0.8736358227473318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,9096,104,1.00 [0.87-1.14],0.963017820970132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,9194,103,1.19 [0.78-1.81],0.4108131333348658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,9143,103,0.83 [0.46-1.49],0.5301592553213789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,8987,101,1.14 [1.00-1.29],0.0551888051901965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,8988,99,1.08 [0.73-1.59],0.70841690584452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,9268,104,1.01 [0.69-1.47],0.9602336848231444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,8028,96,1.34 [0.93-1.92],0.1112863102308516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,8080,98,0.94 [0.67-1.34],0.7467484396648492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,9268,104,1.68 [1.32-2.13],2.042616862487232e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,9213,104,1.31 [0.75-2.30],0.3468260687898802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,7727,93,1.21 [0.73-2.01],0.4675233343379841
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,8892,100,1.08 [0.66-1.77],0.7520029650347846
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,7909,96,1.53 [0.68-3.41],0.3015780542296926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,9284,105,1.65 [1.07-2.54],0.023308692497091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,7799,96,1.39 [1.09-1.78],0.0074502484435476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,9284,105,1.19 [0.82-1.73],0.3705571212600343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,7849,98,1.23 [0.86-1.75],0.2604142892958544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,8060,98,1.19 [0.79-1.81],0.3985722887487259
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",8669,98,0.91 [0.47-1.79],0.7920094229322562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",7826,99,0.85 [0.49-1.47],0.5702227305097893
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",9153,102,0.97 [0.78-1.21],0.7944301308743589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",9151,106,1.05 [0.82-1.35],0.7182401730358831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",8968,102,1.11 [0.77-1.59],0.5870741441484856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",7826,99,1.00 [0.60-1.68],0.9895803381604416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",7799,96,0.89 [0.68-1.18],0.4245945701008391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,9178,102,0.74 [0.54-1.02],0.0642573610962614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,9284,105,0.87 [0.59-1.28],0.47394454193658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,9229,104,0.87 [0.48-1.61],0.6675242644745196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,8064,99,0.89 [0.72-1.11],0.3136048683030138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,8016,96,0.86 [0.57-1.30],0.4791431036829892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,9188,103,0.81 [0.61-1.06],0.1268344113880375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,9153,102,1.05 [0.68-1.63],0.8162811838336512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,9191,106,1.00 [0.63-1.58],0.9860398044941434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,9129,106,1.00 [0.85-1.18],0.9890450960167676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,7826,99,0.88 [0.58-1.31],0.5196519837185414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,9238,106,1.13 [0.67-1.92],0.638954578077747
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,7888,96,1.09 [0.56-2.13],0.8038965038183048
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,7837,96,0.72 [0.32-1.65],0.4395589606949149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,8915,102,0.66 [0.26-1.73],0.4002289888911394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,9270,104,0.95 [0.68-1.33],0.756067719759832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,8037,96,1.06 [0.67-1.69],0.7999142110408485
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,9023,101,0.70 [0.46-1.04],0.0781704945694333
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,8037,96,0.87 [0.62-1.23],0.436070928356116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,9284,105,0.87 [0.69-1.08],0.2141264882151697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,9153,102,0.95 [0.82-1.10],0.4895497239952759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,7849,98,0.98 [0.78-1.25],0.8929931731432966
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,9110,106,1.32 [0.83-2.10],0.2441760053832413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,9245,106,1.09 [0.81-1.46],0.5784046980486577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,9263,106,0.81 [0.61-1.08],0.1463912619137826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,8070,98,2.38 [0.92-6.15],0.0736437527579797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,8052,99,0.91 [0.66-1.27],0.5856502062458147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,8953,103,0.82 [0.52-1.31],0.4146800852234392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,8080,98,0.89 [0.59-1.37],0.6036225129142154
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,9214,103,1.26 [0.91-1.74],0.1692721347325271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,8052,99,0.90 [0.73-1.10],0.2967218698089994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,8064,99,1.18 [0.88-1.57],0.2674370198788508
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,9249,103,1.50 [1.04-2.15],0.0292045709132388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,7655,94,0.81 [0.60-1.09],0.1654603402258932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,7799,96,1.10 [0.86-1.40],0.4355136978906866
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,8052,99,0.89 [0.48-1.64],0.702794720361094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEP,Leptin,9188,103,1.31 [0.96-1.78],0.0853046502648615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,9188,103,0.60 [0.33-1.09],0.0954577657518174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,8052,99,1.08 [0.74-1.56],0.7028514272752329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,9188,103,0.98 [0.58-1.66],0.9537563970765748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,9210,102,0.69 [0.39-1.24],0.2174007067327311
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,8084,99,1.47 [0.85-2.54],0.1697227446323458
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,9191,106,0.88 [0.64-1.21],0.4293866798228413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,9162,100,1.39 [0.94-2.06],0.1013882610466553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,9263,106,0.85 [0.63-1.15],0.2870945680828926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,9201,105,1.27 [0.75-2.15],0.3762114735409716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,9238,106,0.58 [0.35-0.96],0.0334748220628434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,8987,101,0.98 [0.79-1.23],0.8852322090540387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,9211,105,0.88 [0.66-1.19],0.4173103931144329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,8968,102,0.95 [0.66-1.38],0.8013099911253624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,9168,106,0.93 [0.46-1.89],0.8388907948758402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,9199,105,0.89 [0.55-1.43],0.6309400036822299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,8080,98,0.92 [0.83-1.03],0.1600147861565616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,7826,99,1.12 [0.79-1.57],0.5284729447570733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,9172,103,0.60 [0.35-1.04],0.0679361487807789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,8064,99,1.09 [0.84-1.42],0.4964020451537467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,9300,104,0.87 [0.46-1.65],0.6622114693525597
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,9269,102,1.07 [0.64-1.78],0.8084239209186406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,9023,101,1.38 [0.94-2.04],0.1011622697599537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,9300,104,1.03 [0.80-1.32],0.8264846366459455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,7888,96,1.11 [0.81-1.51],0.5257657432607803
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,8011,98,0.85 [0.61-1.18],0.3259151493754118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,8060,98,1.42 [0.74-2.74],0.2942689154706065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,8052,99,1.36 [0.85-2.19],0.2018975030157509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,7799,96,0.93 [0.66-1.30],0.6580176812088634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",7888,96,0.91 [0.72-1.16],0.4444201032081197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),7892,97,0.92 [0.83-1.03],0.1515400994552116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,9153,102,0.72 [0.41-1.26],0.2518012203131478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,9188,103,0.90 [0.62-1.31],0.5789648521090851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,8901,104,0.85 [0.63-1.14],0.2812084704698735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,7826,99,0.88 [0.65-1.19],0.3939019269240116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,7826,99,1.01 [0.75-1.35],0.9730663462479274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,7852,92,1.19 [0.83-1.72],0.3495616657199661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,8084,99,0.66 [0.32-1.37],0.2663603042359148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,9232,103,1.08 [0.65-1.79],0.7686013979522252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,7816,97,1.52 [0.89-2.59],0.1220299085436538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,9153,102,0.62 [0.31-1.24],0.1780631923471944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,9188,103,1.54 [0.96-2.44],0.0706575416375575
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,7852,92,0.83 [0.47-1.48],0.5340889801998263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,7852,92,1.03 [0.83-1.27],0.8134134047523277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,9263,106,1.00 [0.74-1.33],0.9766615696252008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,9153,102,1.05 [0.66-1.67],0.8354681658085383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,8029,98,1.02 [0.65-1.62],0.9248627688674642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,7852,92,1.03 [0.68-1.55],0.9060357967485968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,8064,99,1.01 [0.68-1.52],0.9542222657288112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,8037,96,0.90 [0.59-1.37],0.6128233821135911
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,9023,101,1.01 [0.63-1.62],0.95572159028291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,7852,92,0.89 [0.52-1.51],0.654468727938737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,8052,99,0.82 [0.38-1.76],0.6054413242177498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,8987,101,1.18 [0.89-1.56],0.2468134461048604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,7935,94,1.17 [0.98-1.40],0.0737423108845559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,9168,106,0.86 [0.55-1.34],0.5002791206415047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,9168,106,1.42 [0.97-2.08],0.0736167613935024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,9268,104,0.74 [0.54-1.02],0.067644923689653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,8037,96,0.99 [0.57-1.70],0.9651486082737972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,9300,104,0.75 [0.44-1.30],0.3078624981171464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,8987,101,1.30 [0.98-1.73],0.0719905525471898
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,9166,105,1.12 [0.61-2.04],0.7172151531516237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,9023,101,0.88 [0.56-1.39],0.5935561755943155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,8037,96,0.90 [0.58-1.41],0.6524700877414418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LXN,Latexin,9091,106,0.90 [0.68-1.18],0.4305223310561781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,9173,104,1.26 [0.82-1.93],0.2899721704759093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,9168,106,1.34 [0.84-2.13],0.2159790261746134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,9096,103,0.77 [0.42-1.40],0.3835539308054499
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,9129,106,0.69 [0.41-1.17],0.1703461117144573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,8987,101,0.97 [0.69-1.37],0.8634427229321505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,9153,102,0.92 [0.75-1.13],0.436588810735296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,8968,102,0.79 [0.55-1.14],0.2100194849038226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,9143,102,1.42 [0.85-2.36],0.1832504544348833
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,8987,101,0.82 [0.56-1.19],0.3020834843364123
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,7799,96,1.10 [0.94-1.28],0.218212927035683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,7852,92,1.13 [0.95-1.34],0.1635395873322987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,8084,99,0.71 [0.27-1.84],0.4783585582185375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,7791,95,0.93 [0.52-1.70],0.8246346016691873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,7921,97,0.83 [0.63-1.11],0.2080755635561795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,7888,96,1.33 [0.89-1.98],0.1593614767528793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,9091,106,0.76 [0.50-1.16],0.2079742664165665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,8987,101,0.87 [0.55-1.39],0.568040759253486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,7852,92,0.90 [0.59-1.39],0.6426974836034267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,7935,94,0.87 [0.72-1.07],0.1860936545284309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,8987,101,1.00 [0.69-1.44],0.9967446966219656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,8064,99,1.47 [0.87-2.50],0.1487870261411534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,8037,96,1.40 [0.99-1.98],0.0581178219860245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",7888,96,0.64 [0.29-1.42],0.2746344541406257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,8064,99,1.32 [0.96-1.83],0.089551013964697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",7791,95,1.05 [0.70-1.57],0.8124967422595468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,9238,106,0.86 [0.75-0.99],0.0307893749257355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,9229,104,0.76 [0.40-1.44],0.3934737553739051
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,7826,99,0.81 [0.60-1.09],0.1603302623189238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,7799,96,0.99 [0.53-1.84],0.9825759090056836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,7826,99,1.01 [0.76-1.34],0.96116242868798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,8060,98,0.90 [0.58-1.41],0.6574191369968048
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,8029,98,0.77 [0.56-1.05],0.1021468025309843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,9168,106,0.89 [0.75-1.05],0.1696422290946229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,8987,101,0.95 [0.79-1.14],0.562415341863814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,9110,106,0.87 [0.74-1.01],0.0717362526135989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,7791,95,1.06 [0.68-1.65],0.7850532076255186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,9168,106,0.70 [0.47-1.06],0.0894137937050015
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,7935,94,0.74 [0.56-0.99],0.0402651141245071
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,7791,95,1.06 [0.93-1.20],0.3838450521579257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,8968,102,1.04 [0.75-1.45],0.803125799448435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,9188,103,0.88 [0.45-1.72],0.7172135505904578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",7907,97,0.85 [0.68-1.08],0.191482656061803
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,9110,106,1.16 [0.55-2.47],0.6932268683913525
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,9208,106,1.02 [0.57-1.83],0.9540751252245518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,9115,106,0.92 [0.53-1.61],0.7811411357327028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,8987,101,0.93 [0.76-1.13],0.4453559507228929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAX,Protein max,8968,102,0.80 [0.67-0.95],0.0127841368081777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,9300,104,0.97 [0.69-1.39],0.8862546647710148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,7967,96,0.84 [0.70-1.01],0.0662026606151406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,9245,106,0.78 [0.47-1.29],0.3289313545898998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",8052,99,1.00 [0.63-1.59],0.999539596586502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,7849,98,0.98 [0.79-1.22],0.8645254574828574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,9139,103,0.75 [0.49-1.14],0.1767755628060757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,8029,98,0.53 [0.22-1.26],0.1522907001345186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,9129,106,1.00 [0.78-1.27],0.982176615121307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",8021,96,0.95 [0.58-1.57],0.8541834140520111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDK,Midkine,9210,103,1.02 [0.73-1.42],0.908552168693608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,7852,92,1.84 [1.00-3.36],0.0486113583933737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",7888,96,0.85 [0.68-1.06],0.1453684431185875
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,8987,101,0.83 [0.66-1.06],0.1334883288935019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,7826,99,1.10 [0.76-1.59],0.6052180409254455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,9191,106,0.75 [0.47-1.20],0.2330694455390433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,7826,99,1.33 [0.85-2.10],0.2129433078183168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,9281,103,1.36 [0.55-3.36],0.5117448854600752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,8064,99,0.48 [0.24-0.93],0.0287066019799922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,7921,97,0.52 [0.22-1.21],0.1276039877491773
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,8029,98,1.17 [0.90-1.52],0.2451016261528503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,9188,103,0.96 [0.83-1.10],0.5414549329412199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,9191,106,1.71 [0.86-3.39],0.1228198859563025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,9284,105,0.56 [0.29-1.07],0.0771456483199967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,9199,105,0.85 [0.73-0.98],0.0232964881100576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,9216,104,0.57 [0.25-1.33],0.1936027812567149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,8968,102,0.77 [0.41-1.45],0.4200714639477936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",9168,106,0.74 [0.60-0.92],0.0063437483932003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,9249,103,0.83 [0.62-1.12],0.2336832905097308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,9015,102,1.16 [0.85-1.58],0.3617109949065945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,7852,92,1.10 [0.84-1.44],0.4943039307373507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,7921,97,1.02 [0.55-1.88],0.9543960372684804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,9300,104,1.08 [0.71-1.66],0.7134739848656921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,9199,105,1.11 [0.74-1.65],0.6229055502841854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,9220,106,0.83 [0.68-1.00],0.0503644074245844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,9168,106,0.84 [0.74-0.96],0.010975510615661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,9229,104,0.74 [0.45-1.19],0.2119631189235114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,7852,92,0.99 [0.74-1.34],0.9534346101989052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,9168,106,1.08 [0.95-1.23],0.2418651623302071
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,9190,105,0.82 [0.64-1.05],0.1176657551839277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,9023,101,0.86 [0.61-1.23],0.4220954883685677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,8037,96,0.83 [0.70-1.00],0.0470268268570755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,8060,98,0.88 [0.71-1.08],0.2303978577636273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,9129,106,0.91 [0.77-1.09],0.3154512959242682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,7849,98,0.84 [0.48-1.46],0.5290867370732184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,7791,95,1.09 [0.83-1.42],0.5482355068242042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,9168,106,0.96 [0.79-1.16],0.6766073189967945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,9153,102,0.92 [0.75-1.15],0.4712878163878889
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,8834,98,0.95 [0.78-1.16],0.6443753857682692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,9170,105,0.85 [0.63-1.17],0.3238123970115432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,9188,102,1.15 [0.83-1.61],0.4052887177871473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,8968,102,0.81 [0.47-1.39],0.4363646760415265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,8064,99,1.22 [0.90-1.65],0.2064649646984514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,9199,105,0.99 [0.69-1.41],0.9475822699556032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,9000,102,1.36 [0.94-1.97],0.0994999824192391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,9242,105,1.00 [0.79-1.27],0.9769981057685776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,9178,104,1.03 [0.77-1.38],0.8337471786885815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",7826,99,0.52 [0.33-0.82],0.0047206865039372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,7852,92,1.02 [0.72-1.42],0.928237722635676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,7935,94,1.07 [0.69-1.67],0.7594910335440324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,9171,103,0.95 [0.79-1.14],0.5618321297635502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,7921,97,0.80 [0.59-1.10],0.1681781869849263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,9268,104,0.88 [0.52-1.49],0.6333612607455954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,8060,98,1.57 [0.89-2.76],0.1193491486293919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,7935,94,0.91 [0.54-1.52],0.7168848712009706
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,7791,95,1.42 [0.92-2.19],0.1130374653277636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,7791,95,1.20 [0.98-1.48],0.0842841875144406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,9015,102,0.86 [0.67-1.09],0.2114197046660693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,9153,102,0.79 [0.64-0.99],0.03646950566127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,9220,106,0.85 [0.69-1.06],0.1430341210136901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,9199,105,0.90 [0.62-1.32],0.5993753338268227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,8016,96,1.47 [1.01-2.14],0.0461623190515858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,8070,98,0.74 [0.38-1.43],0.3625593321832401
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,7852,92,0.98 [0.73-1.32],0.902160581291252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",7826,99,0.49 [0.27-0.92],0.0254150716181874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",8052,99,0.90 [0.50-1.64],0.737139688194032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",8968,102,0.81 [0.42-1.59],0.5454611504634022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",7777,95,1.00 [0.45-2.22],0.9910271127425532
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",8052,99,0.96 [0.73-1.27],0.7817204093188497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",7849,98,1.07 [0.57-2.02],0.831665250957219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,9135,101,0.95 [0.70-1.30],0.7454603812982061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,7852,92,0.67 [0.37-1.19],0.1684785072369643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,9150,100,1.01 [0.79-1.29],0.9562483954027192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,9263,106,0.83 [0.57-1.22],0.3461322205787537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,9229,104,0.81 [0.64-1.04],0.0965124455827994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,7936,96,1.03 [0.74-1.43],0.8551181689586228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,9015,102,1.03 [0.73-1.46],0.8502208262742365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,7849,98,0.89 [0.72-1.10],0.2842623100173433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",8060,98,1.15 [0.57-2.31],0.6944691862589663
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,7935,94,0.94 [0.79-1.13],0.5144762335355046
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",8029,98,0.82 [0.66-1.03],0.0919662879121305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,9015,102,0.85 [0.47-1.52],0.5757425751435787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,7826,99,1.11 [0.86-1.44],0.4239780363158968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,8029,98,0.93 [0.78-1.11],0.400307289404853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,8037,96,0.90 [0.73-1.10],0.3110248345726334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,7935,94,0.82 [0.56-1.21],0.3149972008703949
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,8968,102,0.85 [0.59-1.22],0.3714717042329198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,9153,102,1.00 [0.91-1.09],0.9817010155580976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,8080,98,0.99 [0.80-1.21],0.8887489879144999
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,7791,95,1.23 [0.85-1.77],0.2732153236080126
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,9023,101,0.90 [0.72-1.13],0.3755746612517976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,7921,97,0.59 [0.32-1.10],0.0976488695637449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",8064,99,1.03 [0.77-1.37],0.8531897026082924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",7888,96,0.89 [0.68-1.15],0.3678481215998642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,8052,99,1.04 [0.79-1.38],0.7698919976774674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,8064,99,0.86 [0.70-1.05],0.1443257012194615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,7826,99,0.88 [0.56-1.40],0.6003879365218112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,7791,95,1.29 [0.89-1.87],0.1771811788693775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,8080,98,0.98 [0.82-1.16],0.8038454411562901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",7826,99,0.90 [0.54-1.52],0.7016584513843329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,7888,96,1.12 [0.85-1.48],0.4073438732409853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,7888,96,0.89 [0.60-1.31],0.5537943627733591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,7852,92,1.12 [0.92-1.36],0.2424392170587577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",7852,92,1.01 [0.64-1.58],0.9692083877642208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,8052,99,1.09 [0.64-1.85],0.748568026210781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,9023,101,0.93 [0.70-1.22],0.5908145684729886
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,9199,105,1.00 [0.68-1.46],0.9894204672808294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,7799,96,0.97 [0.64-1.46],0.8705192342650987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,7826,99,0.76 [0.48-1.21],0.2560455630087189
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,7921,97,1.04 [0.84-1.29],0.7156338230487969
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,9226,106,0.83 [0.59-1.17],0.2955413538035282
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,8987,101,0.87 [0.60-1.25],0.4531932402358847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,7826,99,0.76 [0.52-1.11],0.1521394035727588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,7852,92,0.96 [0.81-1.14],0.6682248362020201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,9085,105,0.95 [0.70-1.30],0.7701082136111917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,8037,96,0.89 [0.61-1.30],0.5577983776569371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,9188,103,0.87 [0.62-1.21],0.3972567932175285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,7830,98,1.15 [0.84-1.57],0.3724308163663914
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,7875,96,0.77 [0.53-1.12],0.1672152281735336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,7921,97,1.13 [0.45-2.83],0.7904698265451856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,8987,101,0.89 [0.62-1.27],0.5102204911871805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,8015,98,0.64 [0.41-1.00],0.0509955967716912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,8060,98,1.25 [0.75-2.08],0.3951620977501564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",8052,99,0.90 [0.60-1.35],0.6043674127469889
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,9229,104,1.89 [1.02-3.50],0.0426809497022637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,9023,101,0.77 [0.51-1.15],0.2017093092575095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,9245,106,0.92 [0.50-1.70],0.7998034611130533
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,9199,105,0.72 [0.37-1.37],0.3123898882487892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,9263,106,1.01 [0.64-1.60],0.9524910877948344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,9156,106,0.96 [0.78-1.18],0.7104506815712999
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,9238,106,0.89 [0.76-1.05],0.1618958857752763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,9023,101,0.92 [0.62-1.36],0.6709419948431679
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,9155,106,1.09 [0.69-1.74],0.7047498329104036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,8029,98,0.66 [0.36-1.20],0.1750672956875109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,9268,104,1.02 [0.56-1.88],0.9473444045874276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,8968,102,0.84 [0.62-1.14],0.273367257818078
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,8037,96,1.01 [0.76-1.35],0.9377652831502304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,7838,98,1.07 [0.62-1.87],0.8002182221366634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,8029,98,0.85 [0.68-1.06],0.1534227917348991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",8987,101,0.95 [0.75-1.22],0.7058518881168148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,7826,99,1.65 [1.20-2.26],0.0019511661367184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,7826,99,0.96 [0.72-1.29],0.7915886929641859
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,7849,98,0.90 [0.48-1.71],0.7496953463489668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,9172,103,1.04 [0.58-1.88],0.8921376303108455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,9229,104,1.15 [0.67-1.98],0.6142254824894218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,7849,98,0.77 [0.53-1.11],0.1632742972571562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,7849,98,0.57 [0.29-1.14],0.1129663701372847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,8933,102,1.04 [0.69-1.57],0.8514752279147753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,7935,94,0.73 [0.53-1.01],0.0536744549132153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,9229,104,0.70 [0.47-1.04],0.0776108006720136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,9238,106,0.73 [0.39-1.37],0.3254841247428363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,8037,96,1.14 [0.99-1.31],0.0638196272250156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,8052,99,1.27 [0.53-3.00],0.5911530180576201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,8070,98,0.99 [0.75-1.32],0.9692641868488302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,9284,105,1.05 [0.57-1.94],0.8647949085150707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,7849,98,1.05 [0.84-1.31],0.6880503050498032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",9168,106,0.87 [0.72-1.04],0.131602079930869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",9023,101,1.20 [0.90-1.59],0.2151287371005207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,7888,96,0.88 [0.67-1.16],0.3601319350154905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,8052,99,1.32 [1.00-1.75],0.0521080105117551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,7826,99,0.85 [0.65-1.12],0.2514256495032475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,7935,94,1.08 [0.77-1.50],0.6657571149537844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,8987,101,1.01 [0.70-1.45],0.9496179715823766
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",8029,98,0.83 [0.68-1.00],0.0541158875585658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,7826,99,1.00 [0.75-1.34],0.9928826393093348
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,7826,99,0.91 [0.54-1.54],0.7272965617043168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,9129,106,1.29 [0.29-5.66],0.7361286730256392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,8064,99,1.44 [0.80-2.59],0.2258349285780732
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,8060,98,0.68 [0.26-1.79],0.4399022878294996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,7728,93,1.11 [0.58-2.13],0.7587206757042164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,9207,106,0.60 [0.39-0.93],0.0225236059181547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,9199,105,0.96 [0.76-1.20],0.703451501367657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,8987,101,0.76 [0.50-1.14],0.1850987670963497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,7888,96,0.84 [0.56-1.25],0.3792468950952585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,8030,99,0.81 [0.62-1.06],0.1208525332296246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,7852,92,1.03 [0.78-1.35],0.8578087404738581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,7799,96,1.03 [0.70-1.51],0.8841134940956656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,7849,98,1.41 [0.58-3.40],0.4470803077013034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,9208,106,1.19 [0.58-2.43],0.6296986704195215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,8008,96,0.73 [0.54-1.00],0.0469529619944745
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,9129,106,0.90 [0.70-1.15],0.3892532293362459
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,7791,95,1.17 [0.76-1.79],0.4724991600398609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,8052,99,0.94 [0.69-1.27],0.6728430119009697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,9199,105,1.34 [0.64-2.79],0.4332690245693762
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,7826,99,1.11 [0.95-1.29],0.1847726714372987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",8968,102,1.19 [0.84-1.69],0.3363247930964759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",7826,99,1.28 [0.80-2.05],0.3097652125578485
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",8968,102,1.12 [0.84-1.51],0.4366990464718285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,9300,104,1.40 [0.46-4.30],0.5550027996962658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,8080,98,1.11 [0.44-2.79],0.8279001125872447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,9300,104,0.94 [0.57-1.56],0.8113572731674871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,7931,96,1.35 [0.78-2.34],0.2869666148552395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,9188,103,1.55 [0.95-2.56],0.0819114347861726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,7849,98,0.92 [0.50-1.69],0.7849740998141149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,7849,98,1.04 [0.87-1.24],0.6775624967136842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,8064,99,1.45 [0.97-2.17],0.072692039519515
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,9015,102,1.14 [1.00-1.30],0.0551598937970451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,9168,106,1.57 [1.11-2.20],0.0100449076131947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,7826,99,0.96 [0.59-1.58],0.885391366535614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,8987,101,0.89 [0.69-1.15],0.3648637308752473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,9199,105,0.94 [0.60-1.49],0.8077911619737259
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,8080,98,0.81 [0.44-1.49],0.5032716520134697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,9188,103,0.77 [0.45-1.30],0.3226771900900886
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,9268,104,1.45 [1.10-1.92],0.0086589464461731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,9188,103,1.29 [0.71-2.33],0.4001997642525714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,8070,98,0.82 [0.66-1.02],0.069562013343341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,8052,99,1.41 [0.97-2.03],0.0681896168156301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,9259,106,0.86 [0.47-1.57],0.6170775693535784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,9199,105,1.14 [0.63-2.06],0.6649568399745668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,9023,101,0.82 [0.56-1.19],0.3001232441997365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,7852,92,1.32 [0.84-2.09],0.2262883778493611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,9263,106,0.92 [0.71-1.20],0.5433814131074173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",8064,99,0.85 [0.65-1.11],0.2224963327169438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,8060,98,1.51 [0.98-2.31],0.0591239706211305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,9157,106,0.80 [0.66-0.96],0.0184416186433503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,9229,104,1.02 [0.76-1.37],0.8911723720769283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,9168,106,0.91 [0.56-1.46],0.6830930159798199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,8987,101,1.21 [0.86-1.70],0.2680830952587352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,9188,103,1.04 [0.52-2.09],0.902163114713857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,9263,106,0.87 [0.40-1.90],0.7299188745497497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,9188,103,1.23 [1.06-1.44],0.0071821930667794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,9168,106,0.80 [0.64-1.00],0.0464234785400475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,8037,96,1.05 [0.87-1.28],0.5975818334023693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,9252,104,0.85 [0.52-1.39],0.5229431458983258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,9284,105,0.75 [0.57-0.99],0.0402883186979219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,7888,96,1.40 [0.74-2.65],0.297907425869476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,7826,99,0.65 [0.40-1.03],0.0691021649181802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,8012,98,0.79 [0.62-0.99],0.043672663862978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],9153,102,0.76 [0.54-1.06],0.1002721950954846
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,9199,105,0.63 [0.44-0.91],0.0127503765500437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,7849,98,0.91 [0.71-1.15],0.4280547831395717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,7826,99,1.33 [0.85-2.08],0.2096865670757114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,7826,99,0.97 [0.57-1.68],0.9256141792739998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,8968,102,0.88 [0.54-1.43],0.6004221207581593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,7849,98,1.72 [0.90-3.29],0.1035548950893992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,9102,106,1.10 [0.83-1.45],0.5201484635654732
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,8052,99,1.08 [0.69-1.67],0.743348069105801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,8957,102,0.91 [0.67-1.25],0.5663455713972806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,7935,94,1.24 [0.97-1.58],0.0845574807484187
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,8029,98,0.79 [0.60-1.06],0.1164823072436622
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,9153,102,0.98 [0.57-1.69],0.938064437159034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,9199,105,1.17 [0.78-1.76],0.4428092412010769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,7935,94,1.20 [0.93-1.55],0.1689980402327043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,7616,91,0.95 [0.80-1.12],0.5124533997188134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,9113,102,1.08 [0.80-1.45],0.613094469426742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,9238,106,0.77 [0.53-1.13],0.1793104347055995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,9153,102,0.91 [0.69-1.20],0.512341146831232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,7799,96,0.88 [0.58-1.33],0.548956074595462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,8060,98,0.92 [0.77-1.11],0.3769716982668564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,7888,96,0.91 [0.67-1.23],0.528033968784299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,9153,102,0.63 [0.41-0.97],0.0346250277947985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,8056,99,1.04 [0.40-2.72],0.9306539691542842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,8060,98,0.92 [0.56-1.53],0.7508597770079579
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,9208,106,0.94 [0.57-1.57],0.820127108443082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,9137,105,1.09 [0.85-1.39],0.508870280427791
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,9259,106,0.68 [0.29-1.56],0.3585593677613138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,7852,92,1.14 [0.74-1.78],0.5497630340035429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,7799,96,0.92 [0.63-1.34],0.6612780013702784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,8029,98,0.78 [0.55-1.09],0.1405035650341653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,8052,99,1.03 [0.75-1.41],0.8582292606901618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",7888,96,0.95 [0.70-1.28],0.7367434831319404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,9263,106,1.13 [1.00-1.29],0.0555385729725626
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,9151,103,0.70 [0.44-1.12],0.1408368516144815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,7826,99,0.98 [0.71-1.36],0.9068369643363352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,9023,101,0.99 [0.72-1.37],0.9697590459086868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,8957,102,0.84 [0.64-1.09],0.1899311777933449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,9129,106,1.26 [1.05-1.52],0.0151098283062262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,8052,99,1.14 [0.99-1.30],0.0630651374229024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",7935,94,0.88 [0.58-1.35],0.5638972791858641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,9015,102,0.82 [0.59-1.14],0.2365083833345733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,7888,96,1.01 [0.65-1.57],0.9746210543694952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,7776,95,1.09 [0.75-1.58],0.6499176598403265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,8968,102,0.83 [0.61-1.14],0.2539849657837147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,7849,98,1.07 [0.68-1.70],0.7573899520937113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,7983,98,1.38 [0.75-2.52],0.3004899569308433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,8060,98,1.22 [0.73-2.02],0.4464139756307005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,7826,99,1.15 [0.92-1.44],0.2225952732514539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,9247,103,1.13 [0.60-2.14],0.7034957382760416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,9199,105,1.08 [0.57-2.07],0.8109086884858547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,9023,101,1.03 [0.69-1.52],0.8999596237308565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,7935,94,1.00 [0.76-1.31],0.9963883248924434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,9199,105,0.74 [0.53-1.02],0.0686712353985157
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,9168,106,0.91 [0.65-1.28],0.5865044466898469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,7921,97,0.86 [0.56-1.33],0.5040790482236789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,7791,95,1.77 [0.93-3.37],0.080470574327472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,8968,102,0.88 [0.62-1.25],0.475936869316499
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,8029,98,0.79 [0.39-1.59],0.5058635968808686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,7799,96,0.98 [0.77-1.24],0.8587056199003263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,7911,97,0.92 [0.60-1.41],0.7023928782506155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,8052,99,0.89 [0.68-1.17],0.416367357313239
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,9254,103,1.61 [0.82-3.16],0.1681884999826254
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,8052,99,1.76 [0.86-3.63],0.1233978064403695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,9188,103,1.68 [1.05-2.69],0.0304178840330882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,8029,98,0.99 [0.56-1.77],0.9824920339589004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,8029,98,0.85 [0.48-1.50],0.5695086435531307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,8037,96,1.38 [0.88-2.16],0.1658872763565417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,7791,95,1.15 [0.87-1.50],0.3218764005923725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,8037,96,1.32 [0.92-1.88],0.1303899124912275
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,9300,104,1.72 [1.11-2.67],0.015241027382692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,8029,98,0.79 [0.61-1.02],0.0693168109343131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,8064,99,0.79 [0.65-0.97],0.0241609849246855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,9253,104,1.16 [0.79-1.69],0.4429637118444915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,9153,102,1.14 [0.65-2.00],0.6501296866434096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,9263,106,0.88 [0.65-1.20],0.425308444666563
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,9188,103,0.89 [0.72-1.10],0.2749126709944777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,7791,95,1.00 [0.69-1.44],0.9861401712877642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",7791,95,1.35 [1.06-1.72],0.0136373230507805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",7826,99,0.83 [0.56-1.22],0.3337412980790683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",7921,97,0.87 [0.72-1.05],0.1365305629756906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,9300,104,0.95 [0.75-1.21],0.6860600295290016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,9238,106,1.06 [0.86-1.29],0.6006733516121447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,8987,101,1.27 [0.74-2.19],0.3875974883267031
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,9188,103,1.42 [0.78-2.57],0.247040319057403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,9300,104,0.94 [0.57-1.53],0.7907900189457258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,7791,95,0.73 [0.42-1.27],0.2661000197287594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,7921,97,0.62 [0.28-1.41],0.2574764861080971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,8080,98,0.75 [0.53-1.05],0.0909282625050857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,7791,95,1.10 [0.80-1.50],0.5626320751307514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,8052,99,0.90 [0.77-1.06],0.213191570251077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,9238,106,0.91 [0.79-1.05],0.1965913623088298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",8987,101,0.87 [0.59-1.30],0.5025685987565138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,7852,92,0.98 [0.67-1.41],0.8944957684957217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,7791,95,1.12 [0.85-1.47],0.405631182691093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,7826,99,0.85 [0.60-1.20],0.3588457723599907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,7849,98,1.02 [0.66-1.60],0.914516787868014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,9300,104,0.99 [0.45-2.15],0.9725218084623892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,9199,105,0.81 [0.60-1.10],0.1816248459275517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,9199,105,0.65 [0.36-1.17],0.1500239648532164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,7888,96,1.14 [0.62-2.09],0.6819567101769921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,7921,97,1.26 [0.71-2.24],0.4282340184523132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,8070,98,0.85 [0.40-1.79],0.6705935417937978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,7849,98,0.93 [0.79-1.09],0.36970355306693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,8030,98,1.06 [0.87-1.29],0.5549235214418899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,8968,102,0.81 [0.58-1.14],0.2248092989758981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,7791,95,1.13 [0.81-1.58],0.4741680312945724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,7852,92,0.96 [0.70-1.33],0.8211824656053831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",9132,102,0.88 [0.71-1.11],0.2859904638172624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,8070,98,0.96 [0.76-1.21],0.7181765732924738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",8064,99,0.78 [0.54-1.13],0.1837167468415074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,9284,105,1.61 [0.81-3.16],0.1712739498487882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,9269,102,0.88 [0.57-1.35],0.556031733148271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,7982,97,1.19 [0.62-2.29],0.5926370305603713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,7826,99,0.96 [0.70-1.32],0.8038566292537433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,7852,92,0.87 [0.58-1.31],0.5063222511607128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,7849,98,1.10 [0.92-1.30],0.2935476084943921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,8052,99,0.89 [0.75-1.06],0.1831606052251672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,8029,98,1.04 [0.71-1.51],0.8423892410445211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,7791,95,0.99 [0.80-1.22],0.9192366701906504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,9129,106,1.49 [0.83-2.68],0.185808571353917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,7921,97,0.61 [0.39-0.95],0.0305837365963628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,8070,98,0.74 [0.35-1.56],0.4228831385744168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PI3,Elafin,9080,102,0.95 [0.68-1.32],0.759020345537174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",8052,99,0.89 [0.69-1.15],0.3846171752575252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,9076,101,1.13 [0.68-1.86],0.6403509568878553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,9168,106,0.72 [0.54-0.96],0.0271055678719404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,9199,105,1.19 [0.64-2.21],0.5767461692758971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,7849,98,0.75 [0.49-1.12],0.1607188072558633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,9199,105,0.70 [0.47-1.04],0.0808247288483687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,9188,103,0.76 [0.57-1.01],0.0550299726938957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,7921,97,1.07 [0.80-1.43],0.6401896964718937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,7776,95,1.00 [0.78-1.28],0.987007464091169
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,8064,99,0.93 [0.45-1.95],0.8537577423653333
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,7826,99,0.88 [0.62-1.27],0.4982394216089415
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,9214,106,1.01 [0.79-1.30],0.913797868146573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,7935,94,0.97 [0.75-1.27],0.8423779261236152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,9129,106,0.94 [0.71-1.24],0.648626931855135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,9229,104,0.85 [0.43-1.66],0.6285418316205695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,9288,104,0.97 [0.66-1.43],0.8655456391388807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",9155,101,0.86 [0.62-1.20],0.3693228338846028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,9238,106,0.81 [0.66-0.98],0.0347544512443384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,9199,105,1.36 [0.80-2.32],0.2495683749538337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,9281,103,1.10 [0.78-1.55],0.5957270486560834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,9199,105,1.30 [0.80-2.10],0.2950004315876539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,9137,104,0.70 [0.36-1.36],0.2929263277912384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",8060,98,1.27 [0.90-1.77],0.1705445958474549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",7849,98,1.03 [0.66-1.61],0.8872700292284827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",8060,98,0.91 [0.74-1.11],0.3391779432250263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,8060,98,0.88 [0.66-1.18],0.4030680075430463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,7884,95,0.82 [0.33-2.06],0.6753830071971763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,8968,102,1.12 [0.70-1.79],0.6228763121389149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,9188,103,0.74 [0.48-1.15],0.1779078566255466
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,9188,103,0.86 [0.66-1.11],0.2393004302002265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,8042,97,0.87 [0.62-1.23],0.4274443714429684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,9269,103,0.75 [0.45-1.22],0.2445422488348225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,8987,101,1.20 [0.72-2.00],0.4832265341922263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,8060,98,1.58 [0.89-2.82],0.1202835190922263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,9168,106,0.79 [0.64-0.98],0.0313004599175345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,9262,103,0.79 [0.38-1.65],0.5318766244959202
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,9164,103,0.80 [0.54-1.18],0.2513353122067946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,9138,101,0.97 [0.88-1.07],0.5519470261295247
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,7826,99,0.91 [0.70-1.18],0.4656387622175422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,7826,99,0.80 [0.57-1.13],0.2033420978520277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,7852,92,1.14 [0.79-1.65],0.4836935095547097
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,8950,102,0.90 [0.78-1.05],0.1744677450373378
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,8070,98,1.29 [0.95-1.75],0.0993207939540098
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,8060,98,1.05 [0.82-1.35],0.6736985257282921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,9191,106,0.99 [0.93-1.04],0.6516007397451471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,7888,96,0.91 [0.62-1.32],0.6056913272770545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,7799,96,1.24 [0.83-1.85],0.2964744467763168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",9023,101,0.86 [0.71-1.03],0.1073391070870957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,9153,102,0.80 [0.25-2.53],0.6988534851986201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,9229,104,0.78 [0.42-1.47],0.4479078329142676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,7849,98,1.41 [0.98-2.02],0.0643481912648307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,7849,98,0.95 [0.48-1.88],0.8861733749329408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",9153,102,0.84 [0.47-1.48],0.5386309651634834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,7888,96,1.28 [0.96-1.71],0.0884340519565709
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,8070,98,0.60 [0.32-1.10],0.0981488597018417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,9015,102,1.66 [1.01-2.73],0.0449034137402281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,9238,106,0.52 [0.36-0.73],0.0002280588876909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,8080,98,0.97 [0.57-1.63],0.9048035826192412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,8032,98,0.97 [0.77-1.23],0.8289830814587494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,9263,106,0.80 [0.55-1.18],0.2614767061022285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,9210,102,0.79 [0.66-0.95],0.0132790584063254
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,7935,94,1.18 [0.92-1.51],0.2049920206074535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",8080,98,0.79 [0.56-1.10],0.1656686581612278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,7849,98,0.99 [0.54-1.79],0.9673236608905816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,8987,101,0.66 [0.35-1.24],0.1964713278989045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,7849,98,0.99 [0.71-1.38],0.9408258662790084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,8064,99,0.68 [0.46-1.00],0.051301208605099
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,9153,102,0.95 [0.71-1.26],0.7127731201508649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,8037,96,0.88 [0.69-1.12],0.2913664789352737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,9229,104,0.88 [0.73-1.06],0.1772640856437961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,7935,94,0.87 [0.64-1.18],0.3571902520483979
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,8052,99,0.73 [0.56-0.95],0.0199850079409301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,8052,99,1.12 [0.69-1.82],0.6467902534374326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,9188,103,0.84 [0.67-1.05],0.1274300088655247
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,9284,105,0.92 [0.77-1.11],0.3912817742477861
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,8029,98,0.87 [0.74-1.04],0.1284488088304185
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,9129,106,0.63 [0.40-0.97],0.0362590256100668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,7852,92,1.08 [0.84-1.37],0.5554337581964718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,9202,104,1.32 [1.13-1.55],0.0006473278590751
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,8987,101,1.02 [0.74-1.39],0.9252772241787044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,7791,95,1.21 [0.56-2.61],0.6294252803993344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,8080,98,2.13 [1.32-3.44],0.0019386929274668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,8037,96,1.38 [1.07-1.78],0.0136058131162883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,9258,104,1.03 [0.59-1.81],0.9195657819946887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,8944,104,0.80 [0.65-1.00],0.0475588358472611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,7929,97,1.13 [0.84-1.51],0.4191332982024819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",9023,101,0.82 [0.63-1.05],0.1181243111583643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",9284,105,0.76 [0.59-0.96],0.0216355825321699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,9268,104,0.76 [0.56-1.03],0.07356537242941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,9023,101,1.00 [0.55-1.81],0.9990119756148824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,9191,106,0.91 [0.45-1.84],0.7843717454436051
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,8080,98,0.93 [0.64-1.34],0.6935840011321296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,8080,98,1.05 [0.71-1.55],0.8145463878127592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,9023,101,0.59 [0.40-0.87],0.007783681526676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,7852,92,1.29 [0.76-2.21],0.3499535824902562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,9188,103,0.78 [0.64-0.97],0.0226182293385357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,8044,98,0.90 [0.71-1.14],0.3869444860674641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,9023,101,0.96 [0.63-1.46],0.8563222587870005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,7826,99,1.00 [0.66-1.50],0.982259549383057
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,7921,97,0.91 [0.78-1.07],0.2573741357488142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,8987,101,0.84 [0.64-1.11],0.2199653461897728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,9263,106,1.08 [0.86-1.36],0.5246570002457878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,8060,98,1.39 [1.00-1.94],0.0506233939131128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,9226,106,1.38 [0.68-2.81],0.3713835280794036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,7826,99,1.08 [0.68-1.73],0.7357359534884449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,9168,106,1.17 [0.88-1.56],0.2760467794637684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,8084,99,0.67 [0.30-1.46],0.3103741153350213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,7852,96,0.79 [0.58-1.06],0.1177146609931012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,7849,98,1.21 [0.84-1.75],0.301178671084045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,7888,96,1.01 [0.61-1.66],0.9826624576385112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,9245,106,1.23 [0.90-1.69],0.1857930905744199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,7849,98,1.31 [0.83-2.06],0.2409550192149404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,9170,102,1.20 [0.78-1.85],0.4021425093279964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,8060,98,1.05 [0.62-1.79],0.8439311494493545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,9171,103,1.24 [0.82-1.86],0.3096734098681838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,8968,102,0.88 [0.76-1.03],0.1112260607238149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,9268,104,0.98 [0.50-1.95],0.96418626895003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,8958,100,0.74 [0.50-1.11],0.1440278041744309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,7935,94,1.24 [0.72-2.11],0.4394558037638643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,7995,96,0.90 [0.45-1.80],0.7729441735307474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,8029,98,1.19 [0.82-1.72],0.3665069005077399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,8029,98,1.02 [0.95-1.10],0.5850841184458642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,9129,106,1.07 [0.92-1.24],0.3878263619077312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,9168,106,0.74 [0.53-1.01],0.0614829190861893
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,8987,101,0.92 [0.61-1.38],0.68313430363666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,7791,95,1.17 [0.63-2.16],0.6151623544982965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,8052,99,0.88 [0.59-1.32],0.5360223083865283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,7852,92,0.99 [0.69-1.43],0.9595678935850926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,9153,102,1.13 [0.83-1.53],0.440784231325532
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,9117,106,0.92 [0.58-1.46],0.7343191861425673
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,9082,106,1.07 [0.67-1.70],0.7924894139742312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,9168,106,1.10 [0.80-1.52],0.5654801987551256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,7849,98,0.98 [0.70-1.38],0.9224723198867768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,9168,106,1.11 [0.94-1.31],0.2378664869603383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,8987,101,0.84 [0.61-1.17],0.3016666869441814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,7663,92,0.87 [0.73-1.05],0.1519871668876939
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",8968,102,0.77 [0.42-1.38],0.3751420198426275
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,9134,105,1.76 [1.07-2.89],0.0264702089719441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,7784,96,0.66 [0.44-0.97],0.0341296564778328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,8064,99,1.06 [0.84-1.34],0.6130576128741978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,7852,92,1.33 [1.06-1.66],0.0131614306555231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,9168,106,1.26 [0.91-1.75],0.1627928422595514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,8968,102,0.87 [0.55-1.39],0.5634856955885721
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,9015,102,0.98 [0.68-1.41],0.9173151464096824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,7849,98,1.04 [0.73-1.48],0.8362735359156706
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,9129,106,0.90 [0.71-1.13],0.3501399646861215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,9220,106,0.80 [0.67-0.96],0.0163252675900295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,7837,98,0.85 [0.47-1.53],0.5914093517717025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,8064,99,0.72 [0.36-1.44],0.3514439277765574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,8080,98,1.15 [0.48-2.76],0.7518808509854775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,9300,104,0.79 [0.43-1.44],0.4407043443287638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,8029,98,1.76 [1.20-2.58],0.0041330267014589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,8029,98,1.25 [0.55-2.85],0.5884613121190606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,9157,106,1.02 [0.50-2.06],0.9593264352141596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,9102,106,1.20 [0.71-2.02],0.49014180732513
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,8060,98,1.10 [0.64-1.91],0.7212841915301065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,9300,104,1.00 [0.48-2.07],0.99701278295417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,8064,99,0.86 [0.47-1.56],0.6119713967130553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,7921,97,0.83 [0.60-1.16],0.2759098260953341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,8933,102,0.95 [0.69-1.30],0.7452143037103627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,7935,94,0.63 [0.37-1.07],0.0864677352542309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,9168,106,0.80 [0.57-1.11],0.1871740621126848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,9211,103,0.90 [0.77-1.05],0.1698277848211787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,9263,106,0.71 [0.44-1.16],0.1707406678360847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,8037,96,0.72 [0.45-1.15],0.1716352132630069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,8968,102,0.90 [0.63-1.29],0.5708223481770425
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,7888,96,1.44 [0.98-2.12],0.0624818837109771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,7826,99,1.19 [1.00-1.43],0.0559502653456575
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,8084,99,1.05 [0.77-1.45],0.7464689114106595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,9145,102,0.83 [0.55-1.26],0.380003510264073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,9229,103,0.71 [0.37-1.36],0.2986454224648724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,7927,97,1.41 [1.09-1.83],0.0091285682477727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,8064,99,0.75 [0.51-1.08],0.1240780266029618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,8064,99,0.91 [0.76-1.09],0.3279165654625733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,8064,99,0.85 [0.68-1.07],0.1698943197053518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,8037,96,0.84 [0.60-1.17],0.2946178289614114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,7826,99,0.87 [0.64-1.18],0.3737665787920291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,9023,101,0.82 [0.64-1.06],0.1357232413513261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,7826,99,0.93 [0.73-1.19],0.5821318302888079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,7799,96,0.98 [0.68-1.41],0.89996649294654
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,8037,96,1.15 [0.78-1.68],0.4843435170667173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,9168,106,0.81 [0.56-1.18],0.2783640851988926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,8968,102,0.65 [0.43-0.99],0.04709326225676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,7921,97,0.87 [0.68-1.13],0.2983610668925012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,8987,101,0.92 [0.66-1.29],0.6330637389158039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,9023,101,0.81 [0.60-1.10],0.1721386474291692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,7852,92,1.03 [0.78-1.36],0.8284494899793143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,8987,101,0.75 [0.50-1.12],0.1609805191385731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,7935,94,0.85 [0.55-1.31],0.4583195841258578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,7849,98,1.18 [0.63-2.21],0.6059757511889434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,8037,96,0.79 [0.50-1.24],0.303014985547306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,7888,96,1.06 [0.74-1.53],0.752449134552067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,7799,96,1.54 [0.89-2.68],0.1232186969603214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,8987,101,0.74 [0.47-1.15],0.1795360822257967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,7849,98,0.90 [0.67-1.22],0.5025329639353273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,7935,94,0.75 [0.50-1.13],0.172185971561391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,8987,101,1.12 [0.69-1.80],0.6531150171352305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,9259,106,1.01 [0.70-1.48],0.9424167806407432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,8968,102,1.35 [0.87-2.09],0.1784098250426279
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,7791,95,1.01 [0.64-1.58],0.9819297434985214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,8987,101,0.95 [0.69-1.31],0.7613601546700506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,8052,99,1.50 [0.97-2.31],0.0705393299371794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,8976,104,0.95 [0.68-1.32],0.7634892007635052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,8052,99,1.00 [0.77-1.30],0.9927081319956452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,7826,99,1.10 [0.76-1.59],0.6255071352965816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,7791,95,1.12 [0.74-1.70],0.5925893890482441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,7852,92,1.18 [0.93-1.50],0.1627280814841049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,9153,102,0.84 [0.66-1.07],0.1669593282635593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,9153,102,1.41 [1.06-1.86],0.0177831178475861
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,8029,98,1.14 [0.84-1.55],0.387361968011828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,7849,98,1.25 [1.01-1.55],0.0444374648459843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,7888,96,0.95 [0.78-1.15],0.579694450158811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,8037,96,1.03 [0.72-1.49],0.8582899583983946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,9015,102,0.66 [0.38-1.16],0.1484887726666027
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,7888,96,1.31 [0.48-3.54],0.5997512222004744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,8052,99,1.09 [0.80-1.49],0.5761640752140724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,9140,106,0.93 [0.65-1.31],0.6620914569208827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,9300,104,0.94 [0.69-1.28],0.6867527071026471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,9300,104,0.98 [0.74-1.28],0.8640598864999596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,8037,96,1.09 [0.68-1.77],0.7175438517139183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,9208,106,1.08 [0.77-1.50],0.6628445213548633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,7849,98,1.11 [0.78-1.57],0.5628645139674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,9199,105,0.99 [0.53-1.82],0.963648625726972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REN,Renin,9188,103,1.19 [0.98-1.45],0.0754711026994174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,7849,98,1.06 [0.65-1.73],0.8156806336170352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,7791,95,1.05 [0.59-1.88],0.8632248099495633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,9153,102,1.14 [0.74-1.74],0.5593451758047725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RETN,Resistin,9179,101,0.77 [0.50-1.18],0.2294927728039411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",7826,99,0.89 [0.58-1.36],0.5892393823876108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,8037,96,0.90 [0.35-2.33],0.8317208357072399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,8052,99,0.92 [0.71-1.20],0.5461669530630703
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,7935,94,1.23 [0.95-1.58],0.1118668870877052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,9263,106,1.01 [0.58-1.75],0.984071148394878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,9263,106,1.01 [0.53-1.92],0.967791547541858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,8052,99,0.82 [0.58-1.16],0.2610891937183007
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,9023,101,1.00 [0.76-1.32],0.9808548495302376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,9069,105,0.87 [0.75-1.00],0.055987646722211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,7849,98,1.02 [0.69-1.50],0.9352838945416884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,7921,97,1.04 [0.71-1.53],0.8449511281617272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,9232,103,0.89 [0.67-1.19],0.4454025728253111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,8064,99,0.86 [0.71-1.04],0.1277501918736726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,7826,99,1.13 [0.89-1.42],0.3124115437860134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,8052,99,1.09 [0.79-1.50],0.5883421836899312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,7901,97,0.96 [0.62-1.48],0.8453896256353017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,8070,98,1.62 [0.94-2.81],0.0836367391306036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,7888,96,1.16 [0.81-1.67],0.4220574347808981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,9153,102,0.92 [0.78-1.10],0.3636626769186319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,7793,92,1.74 [0.94-3.20],0.0757078317955877
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,8005,96,1.15 [0.65-2.03],0.6328686628693931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,8052,99,1.18 [0.83-1.68],0.3457445746454842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,9268,104,0.91 [0.48-1.74],0.7846117541389317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,7888,96,0.98 [0.53-1.82],0.945628134944348
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,7849,98,0.71 [0.41-1.24],0.226804620352623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,7849,98,1.29 [0.84-2.00],0.2455196522538269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,7935,94,1.23 [0.96-1.58],0.0960490452007624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,8987,101,0.96 [0.73-1.25],0.7413770925124881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,7935,94,0.72 [0.46-1.13],0.1525562440549171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,7888,96,0.89 [0.68-1.17],0.4059076602859484
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,9208,106,1.14 [0.58-2.22],0.7032291140319231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,9263,106,1.56 [0.75-3.20],0.231227408743448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,7888,96,1.77 [0.59-5.37],0.3107421114782424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,9188,103,1.48 [0.86-2.56],0.1562154454686576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,9153,102,0.71 [0.45-1.11],0.1280065158261485
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,7849,98,1.28 [0.71-2.29],0.4166270294694153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,7935,94,1.01 [0.76-1.34],0.9412240767728364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,7852,92,1.08 [0.69-1.70],0.7278732257023702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,7888,96,0.94 [0.56-1.59],0.8269929522779071
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,7826,99,0.90 [0.55-1.48],0.6757482151695432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,7852,92,0.96 [0.82-1.12],0.5807291486968466
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,8987,101,0.92 [0.64-1.32],0.6451139343667676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,8987,101,0.85 [0.65-1.11],0.2370657332055342
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,7799,96,0.89 [0.73-1.09],0.2622052657676691
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,9129,106,1.66 [0.98-2.80],0.0576262777199801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,9268,104,1.59 [0.87-2.88],0.1295937794221944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,9153,102,1.26 [0.68-2.33],0.4576689333950909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,7826,99,1.05 [0.75-1.47],0.7687760513565355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",8052,99,0.88 [0.71-1.10],0.2574332170890056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,9268,104,1.63 [1.01-2.61],0.0436533463799472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,8987,101,1.04 [0.89-1.21],0.6583611493865272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,9263,106,0.82 [0.62-1.07],0.1439172696945296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,7826,99,1.00 [0.58-1.74],0.990997456666115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,9121,103,0.91 [0.61-1.35],0.6350048308393694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,9065,100,0.91 [0.72-1.15],0.4343488264649294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,7849,98,1.58 [1.01-2.46],0.0442172010299429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,8052,99,1.22 [0.88-1.68],0.2396505547619985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,8957,102,1.04 [0.78-1.38],0.7891976383665813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,8037,96,1.18 [0.84-1.65],0.3331896435251422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,9229,104,0.95 [0.70-1.29],0.7241173493183573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,8052,99,1.24 [0.83-1.86],0.2859857664029441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,9015,102,0.75 [0.52-1.07],0.1162217011199193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,8084,99,1.26 [0.81-1.97],0.3078275624970687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,8052,99,0.99 [0.52-1.91],0.987717581518353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,7799,96,0.97 [0.66-1.43],0.8960046212467981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,9168,106,0.81 [0.63-1.05],0.1069691206620339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,7935,94,1.02 [0.79-1.33],0.8650817492530336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,8028,98,0.91 [0.76-1.09],0.2946735649860744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,7826,99,0.58 [0.29-1.17],0.1269272830199657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,7826,99,1.06 [0.74-1.51],0.7684525291366605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,7935,94,0.76 [0.54-1.08],0.123012729548756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,8052,99,1.09 [0.58-2.07],0.786010423542379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,8066,98,0.65 [0.37-1.16],0.1442602675461315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,9153,102,0.94 [0.77-1.16],0.5945632162336607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,9263,106,0.92 [0.52-1.65],0.7826321885199212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,8968,102,1.21 [0.95-1.54],0.1164821914283049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,8959,105,1.67 [1.01-2.73],0.0436631632790826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,9300,104,0.73 [0.48-1.13],0.1584709923232478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,9263,106,1.13 [0.64-2.02],0.670631499151
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,9216,103,1.39 [0.83-2.32],0.2161144806750037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,9208,106,1.04 [0.63-1.72],0.8736500690743658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,9200,105,1.23 [0.90-1.70],0.1996982960319831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,7826,99,1.57 [1.03-2.39],0.0339690437075839
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,7921,97,1.03 [0.48-2.21],0.9404228621843648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,9220,106,0.88 [0.72-1.08],0.2259702169351297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,9023,101,0.75 [0.50-1.13],0.1718593216113083
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,7799,96,0.75 [0.55-1.02],0.0637601019045198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,9232,103,0.87 [0.59-1.27],0.4689225064346995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,7799,96,0.78 [0.49-1.24],0.2967613478158099
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,7852,92,1.56 [0.91-2.68],0.102127419507043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,7852,92,1.18 [0.72-1.94],0.5146073063720461
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,7799,96,1.06 [0.73-1.54],0.776586165134913
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,7888,96,1.66 [1.08-2.56],0.0212772987609668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,8987,101,0.86 [0.65-1.13],0.2746064177200151
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,7855,96,1.03 [0.68-1.55],0.9010726600679528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,8064,99,0.73 [0.36-1.48],0.3882552002935183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,7888,96,1.09 [0.90-1.33],0.3829549492439535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,9168,106,0.57 [0.40-0.80],0.0010286244149674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCT,Secretin,7852,92,0.96 [0.63-1.47],0.8575806752910115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,9188,103,1.43 [0.93-2.19],0.1049261088203713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,9188,103,0.75 [0.51-1.09],0.1331303271213723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,8037,96,0.91 [0.76-1.08],0.2736998053162074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,8029,98,0.78 [0.56-1.07],0.1261066945356144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,7921,97,1.61 [1.06-2.43],0.0240581625455319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,7888,96,0.80 [0.62-1.04],0.0958407050016937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,7888,96,1.00 [0.54-1.85],0.9947482780720766
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,9300,104,0.99 [0.70-1.38],0.9360053707521232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,8084,99,1.48 [0.68-3.24],0.3226907997492612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,8084,99,0.95 [0.40-2.21],0.8972814653790869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,9245,106,0.85 [0.63-1.16],0.3138038937931834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,9168,106,1.10 [0.58-2.10],0.772957625735176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,9188,103,2.13 [1.11-4.07],0.0221614278259719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,7921,97,0.81 [0.50-1.29],0.366099424832937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,9153,102,1.04 [0.55-1.98],0.9042597169758094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,9263,106,0.69 [0.38-1.23],0.2094962005318371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,7849,98,1.32 [0.68-2.55],0.4126417053832013
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,9281,103,1.39 [0.75-2.55],0.296047043222348
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,8052,99,1.21 [0.95-1.55],0.1139663924608187
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,7935,94,0.79 [0.50-1.23],0.2945896301370602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,8047,98,1.44 [0.81-2.56],0.2127114322042787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,9153,102,0.69 [0.36-1.34],0.2710550065549996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,7920,95,0.66 [0.05-8.44],0.7491426394908317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,9300,104,0.62 [0.41-0.94],0.024281921743409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,8904,101,1.09 [0.94-1.27],0.265018216917301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,8043,98,1.26 [0.35-4.51],0.7177141182655735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,7932,96,2.87 [1.27-6.47],0.0111824584972627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,7961,96,1.59 [0.96-2.64],0.0721641465783893
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,8084,99,0.52 [0.15-1.80],0.3002122017210492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,8084,99,1.07 [0.38-3.03],0.8958315840819469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,9100,100,1.10 [0.86-1.41],0.459623416704869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,9169,104,0.78 [0.64-0.96],0.0204940082715153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,9015,102,0.94 [0.66-1.34],0.7399469513685
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,9233,105,0.77 [0.57-1.04],0.0923263094559217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,9284,105,0.85 [0.62-1.19],0.347579349649165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,9129,106,0.77 [0.46-1.30],0.3356536095940763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,8067,99,0.63 [0.17-2.34],0.4894972682408929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,8067,99,0.98 [0.47-2.01],0.9516227439031631
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,9300,104,0.89 [0.68-1.15],0.365207282143048
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,8064,99,0.89 [0.65-1.20],0.4381286532229799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,7955,98,1.67 [0.83-3.36],0.148832681129045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,7929,97,0.59 [0.14-2.52],0.4781646270184678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,8067,99,0.40 [0.14-1.17],0.0940201188622561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,7935,94,0.94 [0.80-1.09],0.4156516682960615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,7907,97,0.47 [0.24-0.93],0.030446772868399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,8029,98,1.17 [0.83-1.63],0.3735126415017291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,8968,102,0.98 [0.74-1.29],0.86476507425289
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,9103,106,1.23 [0.70-2.18],0.4747962305606334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,7852,92,0.86 [0.44-1.68],0.6581890077260277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,9229,104,0.68 [0.36-1.29],0.2359331865327301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,9153,102,0.98 [0.46-2.10],0.9561657538666196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,9153,102,0.92 [0.72-1.17],0.5024955164924734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,9107,106,1.33 [0.91-1.94],0.1373883089739739
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,7921,97,2.01 [1.25-3.26],0.0042773146947562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,8987,101,1.05 [0.78-1.41],0.7568475339259892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,8987,101,1.25 [0.90-1.74],0.1797740739322892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,9188,103,1.05 [0.81-1.36],0.7041465603843339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,7902,97,1.07 [0.77-1.50],0.684640898607066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,8987,101,0.86 [0.72-1.03],0.1039887428907159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,9168,106,0.71 [0.49-1.02],0.0643858060558698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,7799,96,0.87 [0.60-1.26],0.4510361556491227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,8029,98,0.77 [0.49-1.21],0.2592393054429425
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,7891,94,0.97 [0.76-1.23],0.7875188668162301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,8060,98,0.91 [0.68-1.21],0.5056266454926819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,8070,98,0.59 [0.43-0.81],0.0011705031287049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,7791,95,1.06 [0.90-1.24],0.5011840141812453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,7807,99,0.89 [0.69-1.14],0.3521039509158769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,7849,98,0.90 [0.57-1.43],0.6694061294911491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,8080,98,1.77 [1.04-3.00],0.0355298911146301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",9220,106,0.84 [0.69-1.03],0.10243496142542
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,7935,94,0.83 [0.49-1.41],0.4857237939259957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,9216,104,0.77 [0.52-1.14],0.1887963023296015
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,9238,106,0.98 [0.66-1.46],0.9305711713496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,9168,106,1.65 [0.99-2.73],0.0530772416810395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,8968,102,1.09 [0.89-1.33],0.4072743168780774
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,9199,105,1.08 [0.92-1.26],0.3608554317734459
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,9268,104,1.07 [0.64-1.81],0.7879714868262392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,9188,103,1.14 [0.60-2.16],0.6857619568562501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,7888,96,1.27 [0.82-1.96],0.2924469283114105
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,9251,104,0.76 [0.42-1.38],0.372181944236805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,7888,96,0.73 [0.33-1.59],0.4276452087851315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,9220,102,1.10 [0.80-1.51],0.5502913314341213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,9185,106,0.91 [0.63-1.32],0.6292711341987041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,7849,98,1.03 [0.81-1.30],0.8339579804000028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,9153,102,0.86 [0.70-1.05],0.1337317469491005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",8968,102,0.64 [0.43-0.94],0.0235570413133346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,9023,101,0.94 [0.68-1.29],0.6824348526965051
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,9110,106,0.84 [0.66-1.06],0.1448786649520203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,9238,106,0.87 [0.74-1.02],0.0945091082386352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,7826,99,1.12 [0.71-1.76],0.62360592571492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,8052,99,0.89 [0.74-1.08],0.2384349828322143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,9023,101,0.73 [0.57-0.92],0.0093887938146018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,8987,101,0.89 [0.55-1.44],0.6287286348071441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,9168,106,0.71 [0.52-0.96],0.0251538938889517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,8987,101,1.11 [0.80-1.54],0.5482546063988335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,7826,99,1.48 [0.81-2.68],0.1993105883267533
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,8037,96,0.69 [0.43-1.11],0.1287540739014861
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,8968,102,1.10 [0.82-1.47],0.5286591662945961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,7852,92,0.92 [0.61-1.39],0.6930726747814803
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,8968,102,0.84 [0.62-1.13],0.249392706334156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,7791,95,1.25 [0.95-1.65],0.1150718689899437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,7791,95,0.99 [0.65-1.49],0.9452474454715496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,8968,102,0.59 [0.33-1.04],0.0681249311232636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,9168,106,1.40 [1.15-1.70],0.0009229512921855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,7852,92,1.07 [0.82-1.38],0.6292686931072164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,8080,98,1.13 [0.75-1.71],0.5487736332822587
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,7826,99,0.92 [0.71-1.19],0.5127873672209532
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,7921,97,0.79 [0.62-1.01],0.0569087703006857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,8029,98,1.04 [0.70-1.53],0.8566038779551051
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",7791,95,1.14 [0.85-1.52],0.3910725271763566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,8968,102,1.01 [0.72-1.43],0.940174267290494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,7849,98,0.95 [0.51-1.76],0.8637050411523417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,9268,104,2.08 [1.32-3.28],0.0017036102845642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,9015,102,0.88 [0.53-1.49],0.6439643451318219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,7935,94,1.19 [0.98-1.45],0.0723388764927312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,8029,98,0.96 [0.76-1.22],0.7252948095940155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,8013,97,1.15 [0.75-1.78],0.5230685057957365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,8987,101,0.98 [0.79-1.22],0.8563516999596044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,8037,96,0.96 [0.72-1.29],0.8071268165117862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,8037,96,0.86 [0.58-1.28],0.4647596672976664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,9153,102,1.20 [0.48-3.00],0.6893555740593384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,8968,102,0.82 [0.63-1.07],0.1419970229565077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,7791,95,0.88 [0.60-1.30],0.5265062662702461
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,8029,98,0.78 [0.53-1.13],0.1891543464014815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,9268,104,1.37 [0.81-2.32],0.2409479958338476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,9238,106,1.19 [0.76-1.86],0.4528509307356542
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,9215,105,1.02 [0.70-1.48],0.9158540253266793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,7849,98,0.95 [0.65-1.40],0.8121877892165621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,9232,106,1.21 [0.91-1.59],0.1856103809378295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,8037,96,0.91 [0.69-1.20],0.5038536280135324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,7799,96,1.11 [0.84-1.48],0.4532236448903345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,8054,98,0.96 [0.78-1.19],0.703531364759065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,9188,103,0.87 [0.72-1.06],0.1701697218452955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,7799,96,0.77 [0.50-1.18],0.2303291964132707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,9229,104,0.87 [0.72-1.06],0.1649179274429863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,8052,99,0.93 [0.66-1.30],0.6611263127070461
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,7921,97,0.97 [0.81-1.15],0.7215519854539488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,9129,106,1.12 [0.87-1.44],0.3724871069856965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",7888,96,1.17 [0.67-2.03],0.584055332953696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',8060,98,0.81 [0.47-1.39],0.4344967407042971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,7826,99,1.03 [0.75-1.40],0.8747906774294555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,7921,97,0.81 [0.56-1.16],0.2499211072545706
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,8029,98,0.87 [0.54-1.40],0.5629587712204309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,8037,96,1.07 [0.85-1.36],0.5452387492473265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,7888,96,0.93 [0.47-1.83],0.8313059320805448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,9188,103,0.83 [0.63-1.08],0.1624927858160745
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],9036,105,0.88 [0.61-1.26],0.4832515312488143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",9199,105,0.54 [0.33-0.89],0.0164494178535808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,8070,98,1.22 [0.93-1.60],0.1452849974571755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,8052,99,1.47 [1.08-2.01],0.0140762589427436
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,8987,101,1.74 [1.09-2.78],0.0194807232232405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,9221,103,0.87 [0.68-1.12],0.2920541405313404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,9172,103,0.98 [0.60-1.58],0.9190535494695776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,9172,103,1.28 [0.81-2.03],0.2813961960507339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,7852,92,0.98 [0.66-1.46],0.9225961833187504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,8039,99,1.39 [0.62-3.14],0.4248501953211675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,7852,92,1.47 [0.70-3.11],0.3124417996619547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,8052,99,1.60 [0.96-2.67],0.0697751269092062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,8052,99,1.16 [0.86-1.57],0.329597875630583
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,9229,104,0.96 [0.75-1.23],0.7671038815756439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,9214,106,1.10 [0.60-2.02],0.7490369884031762
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPART,Spartin,7921,97,0.86 [0.66-1.12],0.2530904482659863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,8064,99,1.88 [1.03-3.43],0.0402976717921537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,9199,105,1.08 [0.74-1.58],0.6772764627473604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,7921,97,0.99 [0.59-1.64],0.9598996228043672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,9168,106,1.05 [0.82-1.34],0.7098216944935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,9199,105,1.24 [0.73-2.11],0.4283167234659001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,9268,104,1.04 [0.74-1.44],0.8309972175565633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,7826,99,0.98 [0.59-1.61],0.9228400440748382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,9179,105,0.98 [0.48-2.01],0.9579214627122458
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,9238,106,0.99 [0.65-1.49],0.949070986277298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,8029,98,1.03 [0.89-1.20],0.6886288639385152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,9129,106,1.13 [0.57-2.23],0.7219159194635633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,9208,106,0.86 [0.50-1.49],0.5978537217325788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,9150,103,0.94 [0.57-1.55],0.80084945536623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,9288,103,0.70 [0.49-1.00],0.0474471453961876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",7849,98,1.33 [0.86-2.06],0.1955417605069828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,7791,95,1.24 [0.96-1.61],0.1019270156726371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,7935,94,1.14 [0.92-1.42],0.226993619651382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,8060,98,1.08 [0.84-1.39],0.5629121798248446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,9023,101,0.83 [0.68-1.02],0.0705889120974363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",7799,96,1.34 [0.80-2.24],0.2586334562785604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,8060,98,0.70 [0.37-1.31],0.2619416386098107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,9212,104,0.88 [0.76-1.02],0.086164752472345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,9153,102,0.84 [0.63-1.13],0.2530956827745457
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,9168,106,0.83 [0.67-1.04],0.1094811005296495
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,8064,99,0.71 [0.40-1.25],0.2345307333213616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,8968,102,0.98 [0.71-1.35],0.8936621283761987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",7849,98,1.23 [0.75-2.01],0.4167792894580437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,9172,103,1.17 [1.00-1.37],0.0456897638323828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,9245,106,1.03 [0.68-1.56],0.8994826831234115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,7791,95,1.13 [0.58-2.20],0.729878819342214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,8029,98,0.89 [0.61-1.29],0.5369030106273198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,7921,97,0.86 [0.61-1.21],0.3774582102798961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",9153,102,0.60 [0.37-0.99],0.045635744790328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",9300,104,0.54 [0.29-1.01],0.0526489964929075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",7849,98,1.05 [0.69-1.59],0.8175929658208397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,8080,98,1.14 [0.58-2.25],0.703452422841131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,8037,96,1.08 [0.66-1.78],0.7587973577021023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,9110,106,0.87 [0.66-1.14],0.3123090956846649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,7849,98,0.83 [0.63-1.09],0.184698014339048
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,9153,102,0.92 [0.81-1.04],0.1973333715841711
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,7791,95,1.18 [0.92-1.52],0.1955883193996794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,9263,106,1.14 [0.76-1.72],0.5223988598932638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,9189,105,2.61 [1.24-5.46],0.0110623601175421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,7799,96,1.02 [0.79-1.31],0.8973109155774428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,9190,105,0.83 [0.63-1.08],0.1678031795951232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,9015,102,0.88 [0.68-1.12],0.2901527424092884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,8968,102,0.83 [0.62-1.12],0.2188503491873394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,9188,103,0.82 [0.66-1.01],0.0560726831576909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",7791,95,1.13 [0.93-1.37],0.217491869148793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,8987,101,0.89 [0.65-1.23],0.4746151690978195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,7852,92,0.68 [0.36-1.25],0.2120702616441319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,8060,98,0.96 [0.58-1.60],0.8755845676091106
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,9153,102,0.94 [0.69-1.29],0.7131539289879211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,7849,98,0.73 [0.41-1.30],0.2877418529010588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,8987,101,0.91 [0.68-1.22],0.5229835959102362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,7849,98,1.65 [1.12-2.44],0.0121174256886468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,9168,106,0.95 [0.66-1.37],0.7905858211934181
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,8052,99,0.89 [0.69-1.15],0.3844812021087747
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,8987,101,0.70 [0.45-1.11],0.1303433502385028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,8029,98,0.58 [0.34-0.99],0.0472232245927681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,8987,101,0.81 [0.65-1.01],0.0652658012855926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,9263,106,0.86 [0.76-0.98],0.0222504757890385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,9168,106,0.83 [0.59-1.17],0.2887607437775138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,7849,98,1.01 [0.78-1.31],0.9297803675150832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,9263,106,0.87 [0.63-1.20],0.3859022314407604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",8052,99,1.03 [0.76-1.39],0.8714604199729382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,9015,102,0.88 [0.61-1.26],0.4830432842386812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,9199,105,0.56 [0.30-1.04],0.0654634221421416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,8037,96,0.79 [0.49-1.27],0.3268847990541085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,7872,96,1.03 [0.59-1.83],0.9078625449709185
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,7852,92,1.11 [0.82-1.51],0.5121033569619795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,8029,98,0.82 [0.45-1.49],0.5136486460444811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,7921,97,0.82 [0.57-1.18],0.2767305474454522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,7799,96,1.03 [0.75-1.42],0.836951044028057
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,8060,98,0.92 [0.54-1.57],0.7522938175180209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,8064,99,0.98 [0.75-1.28],0.8896487774441476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,7935,94,0.91 [0.75-1.10],0.3272078310900325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,9153,102,0.92 [0.79-1.06],0.2450767228971732
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,8185,90,0.49 [0.25-0.95],0.0353995870120082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,8037,96,1.43 [0.87-2.34],0.1582244586853892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,9153,102,1.70 [1.08-2.68],0.0212414224375819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,7791,95,1.18 [0.89-1.57],0.2400900368724395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,8036,96,0.73 [0.46-1.16],0.1807128920156959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,9023,101,0.78 [0.60-1.02],0.0720006473347405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,7935,94,0.75 [0.50-1.14],0.1779614170978831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,8968,102,0.96 [0.76-1.21],0.7261666633427921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",7852,92,1.12 [0.89-1.41],0.3333870004318233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",8037,96,1.25 [0.77-2.02],0.3654237427941614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,8060,98,0.92 [0.67-1.26],0.59751124407258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,8968,102,1.07 [0.74-1.54],0.7181921611885104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,9153,102,0.87 [0.71-1.07],0.1815761446189688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,9168,106,0.92 [0.73-1.15],0.4453884784657852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,7921,97,0.81 [0.64-1.02],0.0745288144842493
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,9129,106,0.87 [0.74-1.03],0.1091765649374066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,9129,106,0.84 [0.68-1.04],0.11567050388305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,8987,101,0.84 [0.68-1.04],0.1030249388445647
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,7852,92,0.71 [0.42-1.22],0.2190514455920529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,9117,106,0.89 [0.74-1.06],0.1850277664095053
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,9015,102,1.00 [0.80-1.25],0.972790125377336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,7893,92,0.83 [0.45-1.51],0.5386800879977314
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,9288,103,0.56 [0.31-1.01],0.052792835009959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,8064,99,1.07 [0.58-1.98],0.8294397469877298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,7935,94,1.20 [0.91-1.58],0.2007513792345825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,8064,99,0.88 [0.47-1.68],0.7090221936872216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,8968,102,1.01 [0.89-1.13],0.9100260097304465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",7852,92,0.98 [0.59-1.64],0.9482272616386224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,8037,96,1.09 [0.84-1.41],0.5363142326136683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,8968,102,0.87 [0.70-1.08],0.2019612729449498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,7826,99,0.99 [0.63-1.56],0.9661373162541932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,9229,104,1.75 [0.80-3.87],0.162899585527586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,7849,98,1.10 [0.58-2.07],0.7752364441721772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,7914,93,1.00 [0.81-1.22],0.9679620211960864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,7852,92,0.97 [0.57-1.64],0.907822207942398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,7935,94,1.27 [0.87-1.85],0.2112005319146462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,8084,99,0.92 [0.38-2.27],0.8625532313740153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,7799,96,1.14 [0.85-1.52],0.3818504128984725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,9153,102,0.89 [0.71-1.12],0.3132099174615338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,9220,106,0.93 [0.68-1.26],0.6268599049755355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,9194,105,1.17 [0.81-1.69],0.4057823916427179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,9188,105,1.17 [0.66-2.08],0.5811768829109218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,9206,103,0.61 [0.36-1.05],0.0739217675984301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,9244,106,1.25 [0.80-1.97],0.3237945642232231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,8037,96,1.03 [0.88-1.20],0.7223818373460127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,9168,106,1.20 [0.84-1.69],0.3162426097448297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,9270,104,0.89 [0.56-1.43],0.638730564880285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,8037,96,1.22 [0.89-1.68],0.2218601701488985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,9150,105,0.82 [0.44-1.56],0.5544479030154379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,7849,98,1.47 [0.67-3.26],0.3366937803770428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,9229,104,1.24 [0.75-2.03],0.4035591934892055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,9300,104,0.95 [0.57-1.60],0.860121912563251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,9179,103,0.99 [0.79-1.25],0.963811957845536
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,8070,98,1.75 [0.88-3.48],0.1129225111936659
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,7776,95,0.77 [0.58-1.03],0.0784855535652782
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,9188,103,1.14 [0.62-2.12],0.6684901843251474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,9199,105,1.22 [0.78-1.89],0.3883190578454826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,9207,106,1.29 [0.89-1.88],0.1839939956026052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,9134,102,1.25 [0.71-2.19],0.4427069626042246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,9015,102,0.83 [0.53-1.32],0.4350963745011328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,7826,99,1.04 [0.88-1.22],0.650651814706589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,7786,97,0.95 [0.53-1.71],0.8695024273822414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,8026,96,0.85 [0.68-1.07],0.1715828144355014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,9263,106,1.41 [0.79-2.51],0.2412690305153219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,8915,102,0.86 [0.74-1.00],0.056600350431317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,9300,104,1.00 [0.66-1.52],0.9983279830833904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",8949,102,1.04 [0.70-1.52],0.8590849293770977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,7935,94,1.20 [0.73-1.98],0.4682318147504754
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,9245,106,0.97 [0.66-1.44],0.8960809078447444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,8064,99,0.69 [0.41-1.15],0.1568786858622291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,8060,98,0.89 [0.71-1.12],0.3136252767683825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,9115,104,1.03 [0.56-1.90],0.92679153553295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,8064,99,1.51 [0.98-2.32],0.0640244227662285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,9238,106,0.96 [0.84-1.09],0.5240551725468978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,9199,105,0.61 [0.39-0.95],0.0301925645586723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,9158,103,1.25 [0.57-2.73],0.5829074357383119
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,9229,104,0.90 [0.72-1.11],0.3179109349379274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,7799,96,0.80 [0.48-1.34],0.3967717429318346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",7935,94,0.92 [0.57-1.48],0.7269303764192072
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,7849,98,1.43 [0.72-2.82],0.3030003016122222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,7935,94,1.85 [0.78-4.37],0.1618685567120163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,9284,105,1.14 [0.85-1.53],0.3677829609316567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,7849,98,1.17 [0.60-2.27],0.6484352292611864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,7852,92,0.76 [0.50-1.15],0.196998166358382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,7935,94,1.05 [0.73-1.50],0.8046745643886051
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,7826,99,0.81 [0.49-1.32],0.3896020987632755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,7826,99,1.13 [0.85-1.50],0.3924529612901609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,8029,98,0.86 [0.71-1.04],0.1239008743695518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,8037,96,0.91 [0.68-1.22],0.5235022048657132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,7888,96,1.07 [0.78-1.45],0.6794994982049403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,8052,99,1.41 [1.05-1.88],0.0211628586693799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,7791,95,1.11 [0.70-1.76],0.6576364035812783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,7799,96,0.94 [0.72-1.23],0.6683150668644597
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,8047,98,0.80 [0.48-1.32],0.3812151180378996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,9153,102,0.99 [0.82-1.21],0.9474360071840078
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,9088,105,0.94 [0.60-1.48],0.7943696474294601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,9199,105,0.76 [0.59-0.98],0.0342410944769424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,9245,106,0.81 [0.57-1.16],0.253560949868551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,8994,102,1.15 [0.77-1.72],0.497146285682123
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,8029,98,0.67 [0.42-1.08],0.0974110047279076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,9023,101,0.64 [0.39-1.07],0.0882276955685707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,7921,97,0.71 [0.51-1.00],0.049840540729062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,9129,106,0.97 [0.57-1.65],0.9044027879941228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,9129,106,1.35 [1.07-1.71],0.0111961818864943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,9215,102,0.71 [0.50-0.99],0.044781409322665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,9284,105,1.35 [0.89-2.04],0.1553644082471533
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,9191,106,0.43 [0.23-0.80],0.0077698551850116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,9229,104,1.19 [0.73-1.95],0.474807934668748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,9208,106,1.37 [0.80-2.34],0.2454642921727488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,9023,101,1.02 [0.66-1.58],0.9348063558393632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,9208,106,0.71 [0.39-1.29],0.2604503774770368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,7921,97,0.88 [0.54-1.41],0.5912398638566522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,9268,104,1.52 [0.92-2.51],0.1053512990492813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,9199,105,0.91 [0.50-1.63],0.7434767012868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,9199,105,0.90 [0.55-1.46],0.6559452878094875
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,9263,106,1.06 [0.57-1.99],0.8433185446627132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,9270,104,1.45 [0.96-2.21],0.0804994364910863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,9129,106,1.17 [0.88-1.57],0.2803651283525741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,9263,106,0.92 [0.63-1.35],0.6712657327666052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,9129,106,1.34 [0.90-2.01],0.1493398979202568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,9284,105,0.66 [0.34-1.31],0.2379140768461389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,9168,106,1.30 [0.97-1.73],0.0748338175670765
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,9284,105,1.05 [0.58-1.92],0.8695410608606531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,9238,106,0.82 [0.43-1.56],0.5432976659656918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,9290,103,1.07 [0.57-2.02],0.831297603596464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,9129,106,1.03 [0.76-1.39],0.8592971985549641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,8080,98,1.11 [0.65-1.89],0.7054411013672821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,8060,98,0.87 [0.70-1.09],0.2418306362127193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,8080,98,1.09 [0.71-1.68],0.6983236653024864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",9015,102,1.18 [0.94-1.49],0.1584356548820031
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,7935,94,1.32 [0.79-2.22],0.2847355754759089
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,9129,106,1.19 [0.79-1.79],0.3986800032755437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,9199,105,0.57 [0.29-1.12],0.1032996358247647
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,8064,99,0.96 [0.74-1.23],0.7322853874085034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,8029,98,0.95 [0.79-1.15],0.6068647872615616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",7791,95,1.14 [0.79-1.64],0.4846630776504553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,7849,98,0.94 [0.73-1.21],0.6486310553040661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,7888,96,0.90 [0.61-1.34],0.6037364248213681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,8987,101,1.04 [0.68-1.59],0.8527471201830057
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,7849,98,1.13 [0.91-1.40],0.2819333992528887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,7751,92,0.85 [0.57-1.25],0.401624242391801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,9015,102,1.18 [0.75-1.87],0.4642561910016237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,7852,92,1.26 [0.71-2.23],0.4308285275989059
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,7852,92,1.31 [0.88-1.94],0.180287212570834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,7921,97,0.90 [0.75-1.08],0.2414212603261117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,8064,99,0.62 [0.30-1.26],0.1854200019097693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,7826,99,1.15 [0.75-1.76],0.519318734848657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,8987,101,0.82 [0.63-1.06],0.1269325418147749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,9127,105,0.95 [0.63-1.43],0.7901849493680211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,7935,94,1.09 [0.87-1.36],0.4553818084709771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,8968,102,0.87 [0.54-1.40],0.5689797638670857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,7826,99,0.73 [0.45-1.18],0.205097803560357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,7791,95,1.13 [0.87-1.47],0.3618096694749839
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,9271,105,0.75 [0.54-1.03],0.0775393783655654
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,8052,99,1.12 [0.71-1.78],0.6257322551117065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,7849,98,1.53 [0.81-2.91],0.1906402288968776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,9023,101,1.08 [0.83-1.40],0.5617359267481359
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,9168,106,0.89 [0.69-1.14],0.3517175444044377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",7849,98,0.84 [0.47-1.50],0.5619830427483081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,7826,99,0.94 [0.61-1.43],0.7624649986552959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,7935,94,0.66 [0.50-0.86],0.0025888507813397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,8080,98,1.08 [0.83-1.40],0.5817042210027414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,9191,106,0.91 [0.65-1.27],0.5777176441476896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,8070,98,0.76 [0.52-1.12],0.1668227930885067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,9199,105,0.73 [0.42-1.25],0.2488516943146619
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,9268,104,0.74 [0.55-1.00],0.0500307464870765
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,9168,106,0.94 [0.77-1.16],0.5836884842009618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,7918,94,0.83 [0.59-1.15],0.2597440947015236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,8029,98,0.89 [0.75-1.07],0.2244890589840149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,7791,95,0.71 [0.47-1.07],0.1030886845707586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,7852,92,0.96 [0.72-1.27],0.7710329071597878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,9168,106,0.91 [0.74-1.11],0.3508501041555124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,8037,96,0.92 [0.73-1.15],0.4447184658776989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,7826,99,0.50 [0.31-0.82],0.0060491068558231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,7849,98,1.06 [0.81-1.38],0.6920773024793405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,8052,99,0.80 [0.59-1.10],0.1714571621259422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,9188,103,1.04 [0.85-1.27],0.7153371087471936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,9015,102,0.95 [0.71-1.27],0.7230344091690815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,7826,99,0.76 [0.46-1.27],0.299771818781364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,9015,102,0.93 [0.47-1.85],0.8457587903887517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,7826,99,1.02 [0.71-1.47],0.9231397593464498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,7799,96,0.89 [0.70-1.13],0.3549469831101579
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,8029,98,0.94 [0.78-1.13],0.5214740223789155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,7849,98,0.55 [0.33-0.94],0.0289554167348316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,8946,102,0.81 [0.63-1.03],0.0866157964920285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,7852,92,0.94 [0.62-1.43],0.7768159785099479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTN,Titin,7826,99,1.26 [0.99-1.60],0.0649154515881186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,7992,97,1.20 [0.55-2.62],0.6485282919811723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,7799,96,1.10 [0.54-2.24],0.7969826567865242
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,8080,98,0.85 [0.67-1.08],0.1817865608750057
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,7935,94,1.16 [0.93-1.44],0.1943741153991606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,9129,106,0.90 [0.74-1.10],0.3058367539829813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,7938,96,0.92 [0.59-1.44],0.7276932964815079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,9229,104,1.31 [0.70-2.43],0.3945370960140952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,9263,106,0.84 [0.65-1.10],0.2134669066027629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,8060,98,0.84 [0.57-1.24],0.3888475135287574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,7784,96,1.03 [0.85-1.25],0.7271205277443009
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",9199,105,0.61 [0.41-0.91],0.015372450180651
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,9121,103,0.75 [0.57-0.99],0.0404960268686675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,9188,103,1.35 [0.72-2.54],0.3453699929292825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",7849,98,0.75 [0.56-1.01],0.0593902356094073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,9153,102,0.99 [0.60-1.62],0.9596429035732364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,8037,96,1.41 [0.77-2.59],0.2605052036485924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,8064,99,0.85 [0.61-1.17],0.3133862189944548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,7849,98,0.63 [0.42-0.96],0.0321370687062973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,7826,99,1.00 [0.67-1.50],0.982126785688718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,7921,97,0.89 [0.66-1.19],0.4386001070015252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,8029,98,0.91 [0.79-1.04],0.1687958763396793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,7826,99,1.09 [0.91-1.30],0.3674697887936463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,7826,99,0.82 [0.45-1.52],0.5292762233167237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,9129,106,1.10 [0.70-1.72],0.6763825322429212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,9277,103,0.74 [0.55-1.00],0.0497580485502283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,7849,98,1.05 [0.49-2.25],0.8968612306775845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,7791,95,1.03 [0.73-1.44],0.8727020151327194
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,8037,96,0.92 [0.51-1.67],0.791164110106778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,8064,99,1.17 [0.95-1.43],0.1312595857928276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,7799,96,0.97 [0.65-1.45],0.8785772298964971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,7921,94,1.05 [0.75-1.47],0.7869452868635561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,7921,97,0.87 [0.66-1.16],0.3508421925817282
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,7852,92,0.97 [0.72-1.30],0.8150354539853213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,9153,102,0.88 [0.72-1.07],0.1886271552322404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,8037,96,0.85 [0.64-1.13],0.2586650617619888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,8060,98,1.35 [0.87-2.09],0.1866882720549641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,7826,99,1.09 [0.87-1.35],0.4588597714633634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,9015,102,0.94 [0.78-1.14],0.542784292511904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,8987,101,0.92 [0.65-1.29],0.6193915785706382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,9015,102,0.73 [0.50-1.07],0.1059951690419755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,7849,98,0.83 [0.66-1.05],0.1166287070735287
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,9168,106,0.76 [0.61-0.95],0.0148044259880874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,9058,104,0.74 [0.38-1.43],0.3701645196903131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,8070,98,0.81 [0.61-1.06],0.128669909702429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,9153,102,0.55 [0.22-1.36],0.1933273215580422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,7799,96,0.94 [0.77-1.15],0.5516971187208146
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,9226,106,1.50 [0.81-2.78],0.1935302671851193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,9263,106,0.67 [0.38-1.20],0.1807567163404688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,7791,95,1.16 [0.95-1.42],0.1473798361634209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,9256,105,1.17 [0.88-1.56],0.2758875400572906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,7849,98,0.87 [0.44-1.72],0.6808103811080521
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,9229,104,0.98 [0.72-1.33],0.8920836632622755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,9265,105,1.03 [0.62-1.70],0.9193185790606468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,8052,99,1.57 [0.85-2.89],0.1474612508198104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,9015,102,1.06 [0.90-1.25],0.4615437496443524
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,7888,96,1.90 [0.97-3.69],0.0601325782660372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,8064,99,1.30 [0.78-2.17],0.3136523021348008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,9153,102,1.51 [1.14-2.01],0.004490127228326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,8070,98,1.32 [1.00-1.76],0.0518882710120038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,9153,102,0.70 [0.49-1.01],0.0589982759154459
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,7935,94,0.76 [0.55-1.05],0.0981776272853236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,9153,102,0.96 [0.77-1.20],0.7174602433308652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,8037,96,0.82 [0.66-1.02],0.0689497756373322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,9153,102,0.88 [0.70-1.11],0.2869898297203885
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,8037,96,1.13 [0.65-1.96],0.6730446192067284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,7826,99,1.14 [0.66-1.99],0.6413380894860202
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,8037,96,1.00 [0.74-1.35],0.993512464616942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,9189,105,1.12 [0.74-1.71],0.5905018560325318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,9171,103,0.92 [0.68-1.23],0.552863874005332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,8060,98,1.36 [0.87-2.12],0.1796590748952556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,8968,102,0.91 [0.64-1.31],0.6152295210890841
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,7935,94,1.12 [0.74-1.68],0.586636709149692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,9015,102,0.91 [0.67-1.25],0.5627594735602133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,9263,106,0.70 [0.55-0.90],0.0043283752488595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,8987,101,0.85 [0.47-1.52],0.5746947142716283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,7921,97,0.86 [0.60-1.23],0.4165749180460488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,9249,103,0.86 [0.56-1.32],0.4886907472176602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,7791,95,1.01 [0.80-1.28],0.9487555345110452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,9096,106,1.84 [1.19-2.85],0.0063114393825335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,8052,99,0.93 [0.59-1.45],0.7363971857501844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,9300,104,1.06 [0.84-1.35],0.6247091654320586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",9199,105,0.81 [0.52-1.28],0.3662756718452041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,9023,101,0.83 [0.63-1.09],0.1842193188591096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,9015,102,0.88 [0.72-1.07],0.2129658450792119
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,8968,102,1.04 [0.85-1.29],0.6906678778215677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,8060,98,0.92 [0.70-1.20],0.527446113185617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,7849,98,1.08 [0.80-1.45],0.6221581283924155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,8037,96,1.02 [0.59-1.76],0.9525546688281852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,7862,94,1.18 [0.89-1.57],0.2606766919929522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,9259,104,1.37 [1.06-1.77],0.0145727733496666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,8744,99,1.69 [1.14-2.52],0.0092112968152501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",9103,106,1.89 [1.28-2.78],0.0012385612190609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",9208,106,1.05 [0.64-1.72],0.8435418525049232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,9268,104,1.44 [0.87-2.37],0.152412493911927
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,9023,101,1.21 [0.68-2.15],0.5275361071647452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,9129,106,0.94 [0.68-1.29],0.6874622996577413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,9268,104,1.19 [0.92-1.55],0.1922639177467725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,9257,103,1.32 [0.78-2.24],0.3056230507095472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,7849,98,0.82 [0.57-1.19],0.2970090025563963
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,9229,104,1.01 [0.83-1.23],0.9434625476160416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,8968,102,0.54 [0.32-0.90],0.019324393900208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,8060,98,1.79 [0.95-3.39],0.0717837669144511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",8029,98,0.90 [0.79-1.02],0.1127747563786937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,9153,102,0.94 [0.80-1.10],0.4273725064238665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,8037,96,0.84 [0.45-1.58],0.5882174685324377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,7826,99,1.11 [0.82-1.50],0.4940923591359832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,9023,101,0.95 [0.77-1.17],0.6172493661056673
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,7921,97,0.81 [0.62-1.06],0.1263090804075156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,7849,98,1.11 [0.56-2.20],0.7626109401250156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,7849,98,0.62 [0.33-1.15],0.1304658019294352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,8987,101,0.80 [0.61-1.05],0.1095364833301728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,9015,102,0.79 [0.49-1.28],0.343336939819586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,7826,99,0.81 [0.56-1.18],0.2720640894599319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,8029,98,0.81 [0.65-1.01],0.0638726848264662
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,8060,98,0.44 [0.19-1.03],0.0584756143547652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,7849,98,0.98 [0.59-1.61],0.9268645230528582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,7935,94,1.06 [0.78-1.45],0.7086953422104243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,8037,96,0.93 [0.71-1.22],0.6067414744648552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,8029,98,0.86 [0.64-1.15],0.3019303426539296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,8037,96,0.88 [0.61-1.29],0.5186094771555907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,7888,96,0.97 [0.90-1.04],0.3330570399572262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,7791,95,0.71 [0.34-1.47],0.354712544423828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,7799,96,0.99 [0.81-1.21],0.922811292007414
